Materiały źródłowe

• #1 Sarcoma: What it Is, Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/17934-sarcoma

  A sarcoma is a rare type of malignant (cancerous) tumor that develops in bone and connective tissue, such as fat, muscle, blood vessels, nerves and the tissue that surrounds bones and joints. Treatments include surgery, radiation, chemotherapy, targeted therapy and immunotherapy. […] Your treatment will depend on various factors, including: The type of sarcoma. Its size and location. Your general health. Whether the sarcoma is newly diagnosed or returned (recurrent). […] Your provider will work to remove all cancer cells while sparing as much healthy tissue as possible. […] Radiation therapy uses high-energy X-rays to kill cancer cells while minimizing damage to healthy cells. […] Chemotherapy uses drugs that kill or slow the growth of rapidly multiplying cancer cells. […] Targeted therapy attacks weaknesses in cancer cells without harming healthy cells in the process.

• #2

  https://winshipcancer.emory.edu/cancer-types-and-treatments/sarcoma/treatment.php

  Our sarcoma care team at Winship Cancer Institute of Emory University ranks among the top cancer experts in the world and uses the latest advances for your sarcoma treatment. […] At Winship Cancer Institute of Emory University, we take a comprehensive, compassionate and coordinated approach to treating sarcoma. […] Sarcoma treatments are as unique as the sarcoma tumor itself, and successful treatment depends on a multitude of factors that vary widely from patient to patient and from sarcoma type to subtype. […] Our physicians consider numerous factors when determining an appropriate, individualized treatment plan for patients with newly diagnosed or recurrent sarcomas. Key factors influencing sarcoma treatment options include tumor size, tumor location, involvement of critical neurovascular structures, the biologic aggressiveness of the tumor and whether the tumor has metastasized or spread to other parts of the body.

• #3 Treatment of Soft Tissue Sarcomas, by Stage | American Cancer Society

  https://www.cancer.org/cancer/types/soft-tissue-sarcoma/treating/by-stage.html

  The best chance to cure a soft tissue sarcoma is to remove it with surgery, so surgery is part of the treatment for all soft tissue sarcomas whenever possible. It’s important that your surgeon and other doctors are experienced in the treatment of sarcomas. These tumors are hard to treat and require both experience and expertise. Studies have shown that people with sarcomas tend to have better outcomes when they’re treated at specialized cancer centers that have experience in sarcoma treatment. […] Treatment is generally similar for most types of soft tissue sarcoma, especially for earlier stage sarcomas. But in recent years, as doctors have learned more about the differences between the types, newer targeted therapy and immunotherapy drugs have become important treatment options for some types of advanced soft tissue sarcomas.

• #4 Sarcoma Treatment Centers – SFA

  https://curesarcoma.org/support-resources/treatment-centers/

  Because sarcomas are rare, it is important to find physicians and multidisciplinary treatment centers that have experience with this disease. […] The Sarcoma Foundation of America recognizes sarcoma treatment centers that meet the following criteria: […] A sarcoma medical group consisting of all specialties, including surgical, orthopedic and medical oncologists; radiologists; pathologists; and oncology nursing as well as rehabilitation services. […] At least one group member who belongs to a sarcoma-oriented medical organization, such as the Connective Tissue Oncology Society (CTOS). […] Publications concerning sarcoma in peer-reviewed journals. […] Sarcoma conferences (e.g. Tumor Board), where sarcoma group members meet at least once per month to discuss patient care issues. […] At least 50 sarcoma patients seen per year.

• #5 New strategies in soft tissue sarcoma treatment | Journal of Hematology & Oncology | Full Text

  https://jhoonline.biomedcentral.com/articles/10.1186/s13045-024-01580-3

  Soft tissue sarcomas (STS) have long been a formidable challenge in oncology, partly because of their rarity and diversity, which complicates large-scale studies and slows the advent of new treatments. Traditionally anchored by anthracycline-based chemotherapy, the landscape of STS treatment hasn’t shifted dramatically in the past twenty years. However, recent strides in research are starting to paint a more hopeful picture. Leveraging advanced molecular profiling, researchers are now tailoring treatments to the unique genetic makeup of tumors, with targeted therapies showing promise. Innovations such as NTRK inhibitors for NTRK-rearranged sarcomas and gamma-secretase inhibitors for desmoid tumors are changing clinical practices. The rise of immunotherapy, including novel agents like LAG-3 inhibitors and bifunctional proteins that target both TGF- and PD-L1, offers new avenues for treatment, particularly when combined with traditional therapies like chemotherapy. Meanwhile, the approval of epigenetic treatments for specific sarcoma subtypes heralds a new wave of strategy based on histological specificity, which could lead to more personalized and effective care. While challenges remain, the field of STS treatment is evolving, driven by a deeper understanding of the disease’s biological underpinnings and a commitment to innovative research approaches.

• #6 Sarcoma – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/sarcoma/diagnosis-treatment/drc-20452650

  Treatment for sarcoma often involves surgery to remove the cancer. Other treatments for sarcoma may include radiation therapy, ablation therapy and treatment with medicines. Medicines that help treat sarcoma include chemotherapy, targeted therapy and immunotherapy. […] Which treatments are best for you will depend on the type of sarcoma you have. Your treatment options also might depend on where the cancer is in your body, how fast it’s growing and whether it has spread to other parts of your body. […] The goal of surgery for sarcoma is to remove all the cancer cells. Sometimes surgeons need to remove a limb, such as an arm or a leg, to get all the cancer. This is called amputation. But surgeons try to save the limb when they can. […] Radiation therapy treats cancer with powerful energy beams. The energy can come from X-rays, protons or other sources.

• #7 Treating Soft Tissue Sarcomas | Soft Tissue Sarcoma Treatments | American Cancer Society

  https://www.cancer.org/cancer/types/soft-tissue-sarcoma/treating.html

  If youve been diagnosed with a soft tissue sarcoma, your treatment team will discuss your options with you. Its important to weigh the benefits of each treatment option against the possible risks and side effects. […] The main types of treatment for soft tissue sarcoma are: Surgery for Soft Tissue Sarcomas, Radiation Therapy for Soft Tissue Sarcomas, Chemotherapy for Soft Tissue Sarcomas, Targeted Drug Therapy for Soft Tissue Sarcoma, Immunotherapy for Soft Tissue Sarcoma. […] Treatment for a soft tissue sarcoma will depend on the type, location, and stage of the cancer, as well as your overall physical health. The only way to cure a soft tissue sarcoma is to remove it with surgery, so surgery is part of the treatment for all soft tissue sarcomas whenever possible. […] Its important to discuss all treatment options, including their goals and possible side effects, with your doctors to help make the decision that best fits your needs.

• #8 Current treatment of soft tissue sarcoma

  https://pmc.ncbi.nlm.nih.gov/articles/PMC2566912/

  Sarcomas are rare tumors, representing only 0.8% of new cancers in the United States. […] The most frequent presentation is as an asymptomatic mass. These tumors can present late, especially in the thigh or pelvic regions. […] Surgical excision remains the dominant curative therapy. […] The management of newly diagnosed sarcoma is complicated. The therapeutic goals are improving survival, avoiding local recurrence, maximizing function, and minimizing morbidity. […] High-risk soft tissue sarcomas are defined as high-grade, 5 cm in size, locally recurrent, deep to investing fascia, having previous inadequate surgery or positive margins, and certain subtypes such as leiomyosarcoma or malignant peripheral nerve sheath tumors. […] The timing and order of wide local resection, preoperative or postoperative radiotherapy, and preoperative or postoperative chemotherapy require a multidisciplinary approach.

• #9 Soft Tissue Sarcoma Treatment | Sarcoma Care Team | Parkview Health

  https://www.parkview.com/medical-services/cancer/cancers-we-treat/soft-tissue-sarcoma

  To maximize accuracy of radiation and minimize associated harm, we utilize Intensity Modulated Radiation Therapy (IMRT), which has been demonstrated in studies to result in optimal local control rates for soft tissue sarcomas. […] In some circumstances chemotherapy is utilized, depending upon sarcoma subtype, grade, anatomic location, feasibility of surgical resection, and the presence of metastatic disease. […] At the Parkview Cancer Institute, we utilize multi-agent chemotherapy and immunotherapy for soft tissue sarcoma treatment depending upon clinical scenarios. […] Surgical treatment requires a wide excision, meaning the tumor is removed covered with a barrier of normal tissue to minimize the risk of leaving microscopic cancer cells in the body. Greater than 90% of sarcoma cases can be treated with limb-sparing surgery, avoiding amputation, and thus optimizing function after tumor removal.

• #10 Synovial Sarcoma Treatment & Management: Approach Considerations, Chemotherapy, Surgical Therapy

  https://emedicine.medscape.com/article/1257131-treatment

  Chemotherapy should be considered in patients with extremity tumors larger than 5 cm. […] The efficacy of chemotherapy as adjuvant treatment after surgery has been a controversial aspect of treatment of synovial sarcoma. Chemotherapy has not proved to provide a significant benefit in survival rates in all series. […] However, a retrospective analysis of 271 patients with synovial sarcoma, of whom 41% received adjuvant chemotherapy, found that the 5-year metastasis-free survival (MFS) rate was 60% for those who were treated with chemotherapy and 48% for those who were not. […] Surgical excision is still the cornerstone of treatment for synovial sarcoma. A tumor-free margin of 1-3 cm is recommended. […] Even with microscopically negative margins, patients could develop local recurrence.

• #11 Get treatment for sarcoma | OHSU Knight Cancer Institute

  https://www.ohsu.edu/knight-cancer-institute/sarcoma-diagnosis-and-treatment

  Surgery […] Radiation therapy […] Chemotherapy […] Targeted therapy […] Immune therapy. […] Surgery is the most common treatment for sarcoma. […] Our surgeons use exceptional precision and advanced technology. […] We use minimally invasive techniques. […] We have one of the most comprehensive robotics programs on the West Coast. […] Some patients may need to have part of a bone surgically removed. […] In radiation therapy, doctors aim beams of energy, such as X-rays, at cancer cells to kill them. […] We may treat some types of sarcoma with chemotherapy. […] Chemotherapy fights cancer with drugs that kill cancer cells. […] Targeted therapy is a powerful type of treatment that homes in on a molecular target located on cancer cells. […] Our doctors led a clinical trial showing regorafenib, a targeted therapy drug, can help patients with advanced bone sarcoma. […] Immunotherapy harnesses the power of your own immune system to knock out cancer cells. […] Support and follow-up care is a critical part of your treatment. […] We offer a wide range of support services: […] Learn more about our supportive care at the Knight Cancer Institute.

• #12 Soft Tissue Sarcoma Treatment (PDQ®) – PDQ Cancer Information Summaries – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK65773/

  Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. […] Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. […] Treatment for soft tissue sarcoma may cause side effects. […] Patients may want to think about taking part in a clinical trial. […] Treatment of stage I soft tissue sarcoma may include the following: Surgery to remove the tumor, such as Mohs microsurgery for small sarcomas of the skin, wide local excision, or limb-sparing surgery. […] Treatment of stage II soft tissue sarcoma and stage III soft tissue sarcoma that has not spread to lymph nodes may include the following: Surgery to remove the tumor, such as wide local excision or limb-sparing surgery.

• #13 Treatment for Sarcoma | Fred Hutchinson Cancer Center

  https://www.fredhutch.org/en/diseases/sarcoma/treatment.html

  We offer the latest surgical options, including limb-sparing surgery, bone transplants and metallic implants, if you need them. […] For some subtypes of sarcoma, proton therapy can save healthy tissue and reduce exposure to radiation. […] Conventional EBRT uses a machine called a linear accelerator to send beams of high-energy X-rays (photons) at the cancer. […] IORT is a fast, effective and exact form of radiation that is used during surgery to treat tumors. […] Neutron therapy attacks cancer cells with neutrons. […] Chemotherapy is a major and important part of sarcoma care. […] Targeted therapies are another type of medicine that can be used in sarcoma treatment. […] Radiation therapy may be used before or after surgery to reduce the risk of your sarcoma coming back. […] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) may be able to control advanced disease while also giving you a good quality of life.

• #14 Soft Tissue Sarcoma Treatment Program | Massachusetts General Hospital

  https://www.massgeneral.org/cancer-center/treatments-and-services/sarcoma/soft-tissue-sarcoma

  Your care team may include: […] Medical and/or pediatric oncologists design the most appropriate combination of chemotherapy, immunotherapy, and/or targeted therapy for your particular cancer. […] We offer the full range of chemotherapeutic agents, including angiogenesis inhibitors and molecularly targeted agents to treat patients with the over 50 sub-types of sarcoma. […] Our orthopaedic oncology and spine surgeons are expert in the most advanced techniques, including computer-navigated surgery. […] Our radiation oncologists offer a range of therapies designed to shrink and destroy tumors while protecting normal tissue. […] Research conducted at Massachusetts General Hospital Cancer Center and other cancer centers is leading to better understanding of the genetic basis of soft tissue sarcomas.

• #15 Sarcoma – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/sarcoma/diagnosis-treatment/drc-20452650

  Treatment for sarcoma often involves surgery to remove the cancer. Other treatments for sarcoma may include radiation therapy, ablation therapy and treatment with medicines. Medicines that help treat sarcoma include chemotherapy, targeted therapy and immunotherapy. […] Which treatments are best for you will depend on the type of sarcoma you have. Your treatment options also might depend on where the cancer is in your body, how fast it’s growing and whether it has spread to other parts of your body. […] The goal of surgery for sarcoma is to remove all the cancer cells. Sometimes surgeons need to remove a limb, such as an arm or a leg, to get all the cancer. This is called amputation. But surgeons try to save the limb when they can. […] Radiation therapy treats cancer with powerful energy beams. The energy can come from X-rays, protons or other sources.

• #16 Radiation therapy for soft tissue sarcoma | Canadian Cancer Society

  https://cancer.ca/en/cancer-information/cancer-types/soft-tissue-sarcoma/treatment/radiation-therapy

  Radiation therapy uses high-energy rays or particles to destroy cancer cells. It is sometimes used to treat soft tissue sarcoma. Your healthcare team will consider your personal needs to plan the type and amount of radiation, and when and how it is given. You may also receive other treatments. […] Radiation therapy is given for different reasons. You may have radiation therapy to: […] destroy the cancer cells in the body […] shrink a tumour before other surgery (called preoperative or neoadjuvant radiation therapy) […] destroy cancer cells left behind after surgery to reduce the risk that the cancer will come back (recur) (called postoperative or adjuvant radiation therapy) […] relieve pain or control the symptoms of advanced soft tissue sarcoma (called palliative therapy). […] The following types of radiation therapy are used to treat soft tissue sarcoma.

• #17 Treatment for soft tissue sarcoma – NHS

  https://www.nhs.uk/conditions/soft-tissue-sarcoma/treatment/

  The treatment youll have for soft tissue sarcoma will depend on: […] Soft tissue sarcomas are usually treated using surgery and radiotherapy. […] You may also be offered chemotherapy and targeted medicines. […] Surgery is the main treatment for soft tissue sarcoma. The aim is to remove as much of the cancer as possible. […] If the cancer has spread, you may be offered further surgery. […] Radiotherapy uses high-energy rays of radiation to kill cancer cells. […] You may be offered radiotherapy: to shrink the cancer before surgery […] after surgery to help reduce the risk of the cancer coming back […] to help shrink cancers that have spread to other parts of the body. […] Chemotherapy is not usually used to treat soft tissue sarcoma. […] You may be offered chemotherapy: to shrink the cancer before surgery

• #18 Treatment for soft tissue sarcoma | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/soft-tissue-sarcoma/treatment

  Your treatment depends on several factors. The main treatment for soft tissue sarcoma is surgery. You may also have radiotherapy treatment to reduce the symptoms and help you feel better. The main treatments for soft tissue sarcoma include surgery and radiotherapy. You might also have chemotherapy as part of your treatment. Surgery is one of the main treatments for soft tissue sarcoma. Radiotherapy treats cancer by using high-energy x-rays to destroy cancer cells. Chemotherapy uses anti cancer (cytotoxic) drugs to destroy cancer cells. You might have it as part of your treatment for soft tissue sarcoma. You might have a targeted cancer drug for soft tissue sarcoma. Targeted cancer drugs change the way cells work and help the body to control the growth of cancer. You will have regular follow up appointments after treatment for a soft tissue sarcoma.

• #19 Radiation therapy for soft tissue sarcoma | Canadian Cancer Society

  https://cancer.ca/en/cancer-information/cancer-types/soft-tissue-sarcoma/treatment/radiation-therapy

  Radiation therapy uses high-energy rays or particles to destroy cancer cells. It is sometimes used to treat soft tissue sarcoma. Your healthcare team will consider your personal needs to plan the type and amount of radiation, and when and how it is given. You may also receive other treatments. […] Radiation therapy is given for different reasons. You may have radiation therapy to: […] destroy the cancer cells in the body […] shrink a tumour before other surgery (called preoperative or neoadjuvant radiation therapy) […] destroy cancer cells left behind after surgery to reduce the risk that the cancer will come back (recur) (called postoperative or adjuvant radiation therapy) […] relieve pain or control the symptoms of advanced soft tissue sarcoma (called palliative therapy). […] The following types of radiation therapy are used to treat soft tissue sarcoma.

• #20 Radiation therapy for soft tissue sarcoma | Canadian Cancer Society

  https://cancer.ca/en/cancer-information/cancer-types/soft-tissue-sarcoma/treatment/radiation-therapy

  External radiation therapy may be given before, during or after surgery. It is usually used for stage 2 and stage 3 soft tissue sarcomas to lower the risk of the cancer coming back where it started (called a local recurrence). […] External radiation therapy can help keep the limb working properly and prevent amputation. […] When surgery cant be done, external radiation therapy can be the main treatment. […] Intensity-modulated radiation therapy (IMRT) is a type of external radiation therapy called conformal radiation therapy. […] Stereotactic body radiation therapy (SBRT) delivers precisely targeted high doses of radiation to tumours in fewer sessions. […] Brachytherapy is a type of internal radiation therapy sometimes used for soft tissue sarcoma. […] Brachytherapy may be used after surgery instead of external radiation therapy.

• #21 Sarcoma Treatment Options | Hoag Family Cancer Institute

  https://www.hoag.org/specialties-services/cancer/conditions/bone-soft-tissue-sarcoma/treatment-options/

  Hoag Radiation Oncology offers advanced therapy to effectively treat sarcoma. One therapy that is often used at Hoag is Intensity Modulated Radiation Therapy (IMRT). IMRT improves the delivery of radiation. Studies show that this technique may improve the efficacy of treatment and can reduce the risk of side effects, such as bone fracture in extremity sarcoma. […] Although not utilized in all cases, chemotherapy may be of benefit in certain subtypes of sarcoma. At Hoag, our medical oncologists offer leading edge chemotherapy treatments for sarcoma. Hoags Sarcoma Program also has access to the latest clinical trials that will test and evaluate the efficacy of new drugs for sarcoma. These trials include targeted therapies and immunotherapy.

• #22 Radiation therapy for soft tissue sarcoma | Canadian Cancer Society

  https://cancer.ca/en/cancer-information/cancer-types/soft-tissue-sarcoma/treatment/radiation-therapy

  External radiation therapy may be given before, during or after surgery. It is usually used for stage 2 and stage 3 soft tissue sarcomas to lower the risk of the cancer coming back where it started (called a local recurrence). […] External radiation therapy can help keep the limb working properly and prevent amputation. […] When surgery cant be done, external radiation therapy can be the main treatment. […] Intensity-modulated radiation therapy (IMRT) is a type of external radiation therapy called conformal radiation therapy. […] Stereotactic body radiation therapy (SBRT) delivers precisely targeted high doses of radiation to tumours in fewer sessions. […] Brachytherapy is a type of internal radiation therapy sometimes used for soft tissue sarcoma. […] Brachytherapy may be used after surgery instead of external radiation therapy.

• #23 5 Innovative Soft Tissue Sarcoma Treatment Options | MD Anderson Cancer Center

  https://www.mdanderson.org/cancer-types/soft-tissue-sarcoma/soft-tissue-sarcoma-treatment.html

  Soft tissue sarcomas usually are treated with a combination of therapies that may include surgery, chemotherapy and radiation. […] Your treatment for sarcoma will be customized to your particular needs and may include one or more of the treatment types listed below. […] Surgery is the main treatment for soft-tissue sarcomas. […] You may receive chemotherapy or radiation therapy before or after the surgery. […] Chemotherapy may be used as the main treatment for sarcoma or with surgery or radiation. […] Radiation therapy usually is not used as the main treatment for sarcoma, but it may be used before surgery to shrink the tumor or after surgery to destroy remaining cancer cells. […] Proton therapy delivers high radiation doses directly to the tumor site, sparing nearby healthy tissue and vital organs.

• #24

  https://winshipcancer.emory.edu/cancer-types-and-treatments/sarcoma/treatment.php

  Radiation plays a key role in sarcoma treatment guidelines. […] Radiation is administered for many soft tissue sarcomas, and is an integral component in the management of patients with soft tissue sarcomas of the extremity and trunk. […] Proton therapy is often used in the treatment of chordomas and chondrosarcomas, as well as many other types of soft tissue sarcomas. […] Immunotherapies, which involve the use of medications to enhance the body’s natural defenses to target and attack specific types of cancer cells, have been highly effective in treating certain solid cancers and leukemias. […] In addition to these sarcoma treatment guidelines, participating in clinical trials may be an option. […] Clinical trials provide patients access to new medications that are being developed to treat sarcoma. […] In addition to advanced sarcoma treatment options, Winship also offers a supportive oncology team of specialized doctors and nurses who can help with the physical, psychological and emotional aspects of living with cancer, including symptom management and counseling.

• #25 Radiation therapy for soft tissue sarcoma | Canadian Cancer Society

  https://cancer.ca/en/cancer-information/cancer-types/soft-tissue-sarcoma/treatment/radiation-therapy

  External radiation therapy may be given before, during or after surgery. It is usually used for stage 2 and stage 3 soft tissue sarcomas to lower the risk of the cancer coming back where it started (called a local recurrence). […] External radiation therapy can help keep the limb working properly and prevent amputation. […] When surgery cant be done, external radiation therapy can be the main treatment. […] Intensity-modulated radiation therapy (IMRT) is a type of external radiation therapy called conformal radiation therapy. […] Stereotactic body radiation therapy (SBRT) delivers precisely targeted high doses of radiation to tumours in fewer sessions. […] Brachytherapy is a type of internal radiation therapy sometimes used for soft tissue sarcoma. […] Brachytherapy may be used after surgery instead of external radiation therapy.

• #26 Synovial Sarcoma Treatment & Management: Approach Considerations, Chemotherapy, Surgical Therapy

  https://emedicine.medscape.com/article/1257131-treatment

  Preoperative radiation therapy (RT) is associated with an increased rate of wound problems. This neoadjuvant RT is sometimes proposed before surgery to reduce the size of the tumor. […] RT is usually required in addition to surgery, particularly if the margins are close to vital neurovascular structures. The most common form of RT in this setting is external-beam RT (EBRT) that is directed at the tumor site and that includes a margin of surrounding normal tissue. […] The local radiation dose is usually 40-60 Gy. […] The surgical complications are related to the site involved but include the general complications of wound infection, wound breakdown, neurologic or vascular injury, and hematoma or seroma formation. […] Specific complications associated with this tumor are local recurrence and distant metastases. The risk of local recurrence is directly proportional to the adequacy of surgical clearance. Therefore, a wide excision is mandatory to reduce this risk. […] Follow-up involves clinical examination, MRI of the surgical site, and CT of the chest. After surgical treatment, the authors recommend MRI, CT, and a patient review every 3-6 months for the first 2 years and then every 6 months for the next 3 years.

• #27 Radiation therapy for soft tissue sarcoma | Canadian Cancer Society

  https://cancer.ca/en/cancer-information/cancer-types/soft-tissue-sarcoma/treatment/radiation-therapy

  Brachytherapy usually causes fewer side effects and long-term complications than external radiation therapy. […] Side effects of radiation therapy for soft tissue sarcoma are: […] fatigue […] skin problems, such as redness, blistering and peeling […] less strength and stiff joints in a treated limb […] swelling in a treated limb (called edema) […] thickening and scarring of connective tissue (called fibrosis) […] slow wound healing mainly when radiation therapy is given before surgery […] nausea and vomiting more often from radiation to the abdomen […] diarrhea more often from radiation to the abdomen or pelvis […] difficulty breathing more often from radiation to the chest or lungs.

• #28 Sarcoma – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/sarcoma/diagnosis-treatment/drc-20452650

  For sarcoma, you might have radiation therapy before, during or after surgery to remove the cancer. […] Chemotherapy treats cancer with strong medicines. Some types of sarcoma are more likely to respond to chemotherapy treatment than are others. Healthcare professionals might use chemotherapy before or after surgery. It also can help treat sarcoma that grows large or spreads to other parts of the body. […] Targeted therapy for cancer is a treatment that uses medicines that attack specific chemicals in the cancer cells. By blocking these chemicals, targeted treatments can cause cancer cells to die. […] Your healthcare professional may have your sarcoma cells tested to see if they are likely to respond to targeted therapy medicines. Targeted therapy may treat certain types of sarcoma. It might be used if the cancer comes back or spreads.

• #29 Treatment for soft tissue sarcoma – NHS

  https://www.nhs.uk/conditions/soft-tissue-sarcoma/treatment/

  The treatment youll have for soft tissue sarcoma will depend on: […] Soft tissue sarcomas are usually treated using surgery and radiotherapy. […] You may also be offered chemotherapy and targeted medicines. […] Surgery is the main treatment for soft tissue sarcoma. The aim is to remove as much of the cancer as possible. […] If the cancer has spread, you may be offered further surgery. […] Radiotherapy uses high-energy rays of radiation to kill cancer cells. […] You may be offered radiotherapy: to shrink the cancer before surgery […] after surgery to help reduce the risk of the cancer coming back […] to help shrink cancers that have spread to other parts of the body. […] Chemotherapy is not usually used to treat soft tissue sarcoma. […] You may be offered chemotherapy: to shrink the cancer before surgery

• #30 Treatment options | Soft tissue sarcoma | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/soft-tissue-sarcoma/treatment/treatment-options-for-soft-tissue-sarcoma

  Some people might have chemotherapy before surgery. This is called neoadjuvant chemotherapy. It aims to shrink the cancer and make it easier to remove with surgery. […] People with gastrointestinal stromal tumours (GISTs) that have spread might have a drug called imatinib (Glivec). Imatinib can work very well at controlling the growth of GISTs for several years or more. […] Surgery is the main treatment and it might cure you. Your surgeon aims to remove the cancer and a border of healthy tissue around it. […] You may have radiotherapy before surgery, mostly for large, deep and high grade sarcomas. […] Radiotherapy or chemotherapy (or a combination of both) aims to help keep the cancer under control for longer. And to relieve symptoms. […] Your doctor might ask if youd like to take part in a clinical trial. Doctors and researchers do trials to make existing treatments better and develop new treatments. […] The main treatment for soft tissue sarcoma is surgery. You may also have radiotherapy treatment to reduce the symptoms and help you feel better. A team of doctors and other professionals discuss the best treatment and care for you.

• #31 Medications for Soft Tissue Sarcoma | NYU Langone Health

  https://nyulangone.org/conditions/soft-tissue-sarcoma/treatments/medications-for-soft-tissue-sarcoma

  Chemotherapy given before surgery, also called neoadjuvant chemotherapy, may be used to shrink large tumors, making surgery a more feasible, safe, and successful option. This approach also reduces the need for amputation of a limb and lessens the risk of the cancer coming back. Chemotherapy, on occasion, may be given after surgery to destroy tumor cells that have spread to other parts of the body. […] Based on the subtype of soft tissue sarcoma, your doctor may prescribe targeted medications as part of your treatment. […] Fibromatosis and desmoid tumors, two benign, or noncancerous, forms of sarcoma, may respond to hormone therapy. These tumors have proteins on the cell surface that are sensitive to the sex hormone estrogen, causing them to grow. Blocking estrogen with medications such as tamoxifen can help to inhibit this process, shrinking tumors.

• #32 Treatment options | Cancer Australia

  https://www.canceraustralia.gov.au/cancer-types/sarcoma/treatment-options

  Sarcoma treatment depends on the cancer type, location, spread, general health, and personal preferences, and may include surgery, chemotherapy, radiation therapy, or targeted therapy. […] Treatment options can include surgery, chemotherapy, radiation therapy and targeted therapy. […] Surgery is the most common treatment for soft tissue sarcoma and gastrointestinal stromal tumours in adults. The goal is to remove the entire tumour. […] Along with surgery, some people may receive chemotherapy. […] Chemotherapy is part of the treatment for almost all patients with Ewing sarcoma. […] Along with surgery, some people may receive radiation therapy. […] Targeted therapy aims to destroy sarcoma cells while doing little damage to normal cells. […] For soft tissue sarcoma, treatment of recurrent disease might involve surgery, chemotherapy, targeted therapy or radiation therapy. […] Treatment of recurrent gastrointestinal stromal tumours (GIST) might involve further surgery or targeted therapy.

• #33 Soft Tissue Sarcoma Treatment (PDQ®): Treatment – Health Professional Information [NCI] | Kaiser Permanente

  https://healthy.kaiserpermanente.org/health-wellness/health-encyclopedia/he.soft-tissue-sarcoma-treatment-pdq%C2%AE-treatment-health-professional-information-nci.ncicdr0000062820

  Neoadjuvant chemotherapy with or without radiation therapy has shown response rates of 17% to 32%, 10-year RFS rates of up to 58%, and 10-year OS rates of up to 64%. […] Anthracyclines remain the first-line class of systemic therapy in managing most locally advanced and metastatic soft tissue sarcoma. […] The clinical benefit of adding other drugs to the single-agent doxorubicin regimen is controversial. […] The U.S. Food and Drug Administration (FDA) has approved eribulin, trabectedin, and pazopanib for the treatment of soft tissue sarcomas after failure of a first-line chemotherapy regimen. […] Patients who develop a local recurrence can often be treated with local therapy, such as surgical excision plus radiation therapy (after previous minimal therapy) or amputation (after previous aggressive treatment).

• #34 Soft Tissue Sarcoma Treatment Protocols: Treatment Protocols

  https://emedicine.medscape.com/article/2007168-overview

  A phase II study randomized patients with leiomyosarcomas to gemcitabine (1200 mg/m2 IV on days 1 and 8; every 21 d) alone or gemcitabine (900 mg/m2 IV over 90 min on days 1 and 8) and docetaxel (100 mg/m2 IV over 90 min on day 8; every 21 d) and reported higher response rates in the dual chemotherapy arm (32% vs 27%), with a 3% complete response (CR) rate and significantly longer progression-free survival (6.3 vs 3 mo). […] Treatment is wide excision and irradiation; however, angiosarcoma is highly aggressive and has a propensity for local recurrence, multifocal spread, and early hematogenous dissemination. […] Chemosensitive disease with particular sensitivity to ifosfamide.

• #35 Soft Tissue Sarcoma Treatment Protocols: Treatment Protocols

  https://emedicine.medscape.com/article/2007168-overview

  A phase II study randomized patients with leiomyosarcomas to gemcitabine (1200 mg/m2 IV on days 1 and 8; every 21 d) alone or gemcitabine (900 mg/m2 IV over 90 min on days 1 and 8) and docetaxel (100 mg/m2 IV over 90 min on day 8; every 21 d) and reported higher response rates in the dual chemotherapy arm (32% vs 27%), with a 3% complete response (CR) rate and significantly longer progression-free survival (6.3 vs 3 mo). […] Treatment is wide excision and irradiation; however, angiosarcoma is highly aggressive and has a propensity for local recurrence, multifocal spread, and early hematogenous dissemination. […] Chemosensitive disease with particular sensitivity to ifosfamide.

• #36 Soft Tissue Sarcoma Treatment (PDQ®): Treatment – Health Professional Information [NCI] | Kaiser Permanente

  https://healthy.kaiserpermanente.org/health-wellness/health-encyclopedia/he.soft-tissue-sarcoma-treatment-pdq%C2%AE-treatment-health-professional-information-nci.ncicdr0000062820

  Neoadjuvant chemotherapy with or without radiation therapy has shown response rates of 17% to 32%, 10-year RFS rates of up to 58%, and 10-year OS rates of up to 64%. […] Anthracyclines remain the first-line class of systemic therapy in managing most locally advanced and metastatic soft tissue sarcoma. […] The clinical benefit of adding other drugs to the single-agent doxorubicin regimen is controversial. […] The U.S. Food and Drug Administration (FDA) has approved eribulin, trabectedin, and pazopanib for the treatment of soft tissue sarcomas after failure of a first-line chemotherapy regimen. […] Patients who develop a local recurrence can often be treated with local therapy, such as surgical excision plus radiation therapy (after previous minimal therapy) or amputation (after previous aggressive treatment).

• #37 Soft Tissue Sarcoma Treatment (PDQ®): Treatment – Health Professional Information [NCI] | Kaiser Permanente

  https://healthy.kaiserpermanente.org/health-wellness/health-encyclopedia/he.soft-tissue-sarcoma-treatment-pdq%C2%AE-treatment-health-professional-information-nci.ncicdr0000062820

  Neoadjuvant chemotherapy with or without radiation therapy has shown response rates of 17% to 32%, 10-year RFS rates of up to 58%, and 10-year OS rates of up to 64%. […] Anthracyclines remain the first-line class of systemic therapy in managing most locally advanced and metastatic soft tissue sarcoma. […] The clinical benefit of adding other drugs to the single-agent doxorubicin regimen is controversial. […] The U.S. Food and Drug Administration (FDA) has approved eribulin, trabectedin, and pazopanib for the treatment of soft tissue sarcomas after failure of a first-line chemotherapy regimen. […] Patients who develop a local recurrence can often be treated with local therapy, such as surgical excision plus radiation therapy (after previous minimal therapy) or amputation (after previous aggressive treatment).

• #38 Current treatment of soft tissue sarcoma

  https://pmc.ncbi.nlm.nih.gov/articles/PMC2566912/

  The goal of curative surgical excision is en bloc excision of the tumor and any biopsy tracts with a negative margin of normal tissue of 1 to 2 cm. […] Amputation is now reserved for the small proportion of patients with massive tumors, extensive involvement of the neurovascular bundle, and nonfunctional limbs at presentation. […] Chemotherapy has poor results in treating sarcoma. The role of adjuvant chemotherapy remains controversial because of the absence of convincing level 1 evidence that it improves overall survival. […] Neoadjuvant chemotherapy is indicated in the treatment of rhabdomyosarcoma because, unlike most sarcomas, high response rates are seen in this subtype. […] Radiation can be an effective treatment to decrease local recurrence of soft tissue sarcomas. […] The current National Comprehensive Cancer Network guidelines recommend radiation therapy for extremity sarcomas for high-grade lesions, low-grade lesions 5 cm, or positive margins. […] While advances have been made, the treatment of soft tissue sarcoma still has much room for improvement.

• #39 Medications for Soft Tissue Sarcoma | NYU Langone Health

  https://nyulangone.org/conditions/soft-tissue-sarcoma/treatments/medications-for-soft-tissue-sarcoma

  Chemotherapy and targeted medication side effects may include nausea, vomiting, diarrhea, and lowered levels of red and white blood cells. Low red blood cell levels cause anemia, a condition that can lead to fatigue and shortness of breath. Low white blood cell levels can increase the risk of infection. […] All of these side effects can be managed with medications or other therapies prescribed by your doctor. Specialists at NYU Langones Perlmutter Cancer Center support you through chemotherapy with a variety of services, from support groups to holistic wellness programs. Your doctor can evaluate your symptoms and connect you with the support services that best suit your needs.

• #40 Sarcoma – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/sarcoma/diagnosis-treatment/drc-20452650

  For sarcoma, you might have radiation therapy before, during or after surgery to remove the cancer. […] Chemotherapy treats cancer with strong medicines. Some types of sarcoma are more likely to respond to chemotherapy treatment than are others. Healthcare professionals might use chemotherapy before or after surgery. It also can help treat sarcoma that grows large or spreads to other parts of the body. […] Targeted therapy for cancer is a treatment that uses medicines that attack specific chemicals in the cancer cells. By blocking these chemicals, targeted treatments can cause cancer cells to die. […] Your healthcare professional may have your sarcoma cells tested to see if they are likely to respond to targeted therapy medicines. Targeted therapy may treat certain types of sarcoma. It might be used if the cancer comes back or spreads.

• #41 Sarcoma treatment: what to expect | The Royal Marsden

  https://www.royalmarsden.nhs.uk/private-care/news-and-blogs/sarcoma-treatment-what-expect

  Your treatment options will depend on the tumour’s stage, grade, type, and location, as well as your age and general health. Our specialists will prioritise your needs and preferences when forming their tailored treatment plan. […] Surgery is a common treatment for soft tissue sarcomas and Ewing’s sarcoma, which affects bones and bone tissue. […] In addition to surgical treatment, radiotherapy is another key method in treating soft tissue and Ewing’s sarcomas. […] Chemotherapy involves using strong medications to target and destroy cancer cells throughout the body. […] Unlike chemotherapy, which affects both healthy and cancerous cells, targeted drugs specifically target the abnormalities in cancer cells that allow them to grow and divide. […] Immunotherapy is an emerging treatment option for sarcomas that uses the immune system to fight cancer cells.

• #42 Soft tissue sarcoma | Macmillan Cancer Support

  https://www.macmillan.org.uk/cancer-information-and-support/soft-tissue-sarcoma

  Radiotherapy uses high-energy rays to destroy cancer cells. Radiotherapy may be given before surgery to shrink the cancer, or after surgery, to destroy any remaining cancer cells. It can also be used to relieve symptoms and control sarcoma that has spread or come back. Rarely, when surgery is not possible, it is used on its own. […] Chemotherapy uses anti-cancer (cytotoxic) drugs to destroy cancer cells. Not everyone has chemotherapy. It depends on the type of sarcoma and the risk of it coming back. It may be given after or before surgery. Chemotherapy can also be given to relieve symptoms and to control sarcoma that cannot be completely removed or has spread. […] Targeted therapy uses drugs to find and attack cancer cells. There are different types of targeted therapy, including tyrosine kinase inhibitors (TKIs). Imatinib is a TKI that is often used to treat gastrointestinal stromal tumour (GIST). Some other targeted therapy drugs might be used in some situations to help to control soft tissue sarcoma.

• #43 Treatment options | Soft tissue sarcoma | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/soft-tissue-sarcoma/treatment/treatment-options-for-soft-tissue-sarcoma

  Some people might have chemotherapy before surgery. This is called neoadjuvant chemotherapy. It aims to shrink the cancer and make it easier to remove with surgery. […] People with gastrointestinal stromal tumours (GISTs) that have spread might have a drug called imatinib (Glivec). Imatinib can work very well at controlling the growth of GISTs for several years or more. […] Surgery is the main treatment and it might cure you. Your surgeon aims to remove the cancer and a border of healthy tissue around it. […] You may have radiotherapy before surgery, mostly for large, deep and high grade sarcomas. […] Radiotherapy or chemotherapy (or a combination of both) aims to help keep the cancer under control for longer. And to relieve symptoms. […] Your doctor might ask if youd like to take part in a clinical trial. Doctors and researchers do trials to make existing treatments better and develop new treatments. […] The main treatment for soft tissue sarcoma is surgery. You may also have radiotherapy treatment to reduce the symptoms and help you feel better. A team of doctors and other professionals discuss the best treatment and care for you.

• #44 Soft Tissue Sarcoma Treatment (PDQ®) – PDQ Cancer Information Summaries – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK65773/

  Treatment of stage IV soft tissue sarcoma may include the following: Chemotherapy. Surgery to remove cancer that has spread to the lungs. Targeted therapy with a tyrosine kinase inhibitor (pazopanib or imatinib). […] Treatment of recurrent soft tissue sarcoma may include the following: Surgery (wide local excision) with or without radiation therapy. Surgery (amputation; rarely done). Surgery to remove cancer that has recurred in the lungs. Targeted therapy with a tyrosine kinase inhibitor (pazopanib or imatinib). Chemotherapy. A clinical trial of an immune checkpoint inhibitor (pembrolizumab, nivolumab, or ipilimumab).

• #45 Get treatment for sarcoma | OHSU Knight Cancer Institute

  https://www.ohsu.edu/knight-cancer-institute/sarcoma-diagnosis-and-treatment

  Surgery […] Radiation therapy […] Chemotherapy […] Targeted therapy […] Immune therapy. […] Surgery is the most common treatment for sarcoma. […] Our surgeons use exceptional precision and advanced technology. […] We use minimally invasive techniques. […] We have one of the most comprehensive robotics programs on the West Coast. […] Some patients may need to have part of a bone surgically removed. […] In radiation therapy, doctors aim beams of energy, such as X-rays, at cancer cells to kill them. […] We may treat some types of sarcoma with chemotherapy. […] Chemotherapy fights cancer with drugs that kill cancer cells. […] Targeted therapy is a powerful type of treatment that homes in on a molecular target located on cancer cells. […] Our doctors led a clinical trial showing regorafenib, a targeted therapy drug, can help patients with advanced bone sarcoma. […] Immunotherapy harnesses the power of your own immune system to knock out cancer cells. […] Support and follow-up care is a critical part of your treatment. […] We offer a wide range of support services: […] Learn more about our supportive care at the Knight Cancer Institute.

• #46 New strategies in soft tissue sarcoma treatment | Journal of Hematology & Oncology | Full Text

  https://jhoonline.biomedcentral.com/articles/10.1186/s13045-024-01580-3

  The clinical potential of Mipa was explored in a Phase 1b trial involving patients with advanced sarcomas. […] These promising findings underscore the potential of immunotherapy as a more effective treatment option for certain sarcoma patients when compared to traditional cytotoxic chemotherapy. […] Two ongoing randomized studies are currently exploring novel combinations to further enhance the response rate to PD-1 inhibition in patients with TLS-positive sarcomas. […] The study continues to explore the optimal dosing regimen and extends to investigate potential combinations with other agents like gemcitabine. […] The compelling data from both therapeutic agents emphasize the necessity of routine genomic screening for NTRK fusions in sarcomas to tailor personalized treatment approaches that can significantly improve patient outcomes.

• #47 Advances in the Treatment of Sarcomas

  https://www.targetedonc.com/view/advances-in-the-treatment-of-sarcomas

  Lisa B. Ercolano, MD, discusses some of the advances that have been seen in the treatment of sarcomas. […] Over the past few years, there has been an increase in the number of therapies available for the treatment of patients with sarcoma. Some of these recent advances include CDK4 inhibitors and MDM2 inhibitors for patients with liposarcomas and desmoid sarcomas, gamma secretase inhibitors for patients with Kaposi sarcoma, and FGFR and IDH mutations as potential targets in some forms of soft tissue and bone sarcomas. […] Therapies continue to be investigated, including regorafenib (Stivarga), entrectinib (Rozlytrek), and larotrectinib (Vitrakvi), as well as additional therapies, such as cabozantinib (Cabometyx) and immunotherapies, are being explored for the treatment of sarcomas. […] According to Ercolano, while slight improvements in survival have been observed with different types of therapies, like pembrolizumab (Keytruda) or trabectedin (Yondelis), survival rates have only improved by months rather than years.

• #48 Advances in the Treatment of Sarcomas

  https://www.targetedonc.com/view/advances-in-the-treatment-of-sarcomas

  Lisa B. Ercolano, MD, discusses some of the advances that have been seen in the treatment of sarcomas. […] Over the past few years, there has been an increase in the number of therapies available for the treatment of patients with sarcoma. Some of these recent advances include CDK4 inhibitors and MDM2 inhibitors for patients with liposarcomas and desmoid sarcomas, gamma secretase inhibitors for patients with Kaposi sarcoma, and FGFR and IDH mutations as potential targets in some forms of soft tissue and bone sarcomas. […] Therapies continue to be investigated, including regorafenib (Stivarga), entrectinib (Rozlytrek), and larotrectinib (Vitrakvi), as well as additional therapies, such as cabozantinib (Cabometyx) and immunotherapies, are being explored for the treatment of sarcomas. […] According to Ercolano, while slight improvements in survival have been observed with different types of therapies, like pembrolizumab (Keytruda) or trabectedin (Yondelis), survival rates have only improved by months rather than years.

• #49 Advances in the Treatment of Sarcomas

  https://www.targetedonc.com/view/advances-in-the-treatment-of-sarcomas

  Lisa B. Ercolano, MD, discusses some of the advances that have been seen in the treatment of sarcomas. […] Over the past few years, there has been an increase in the number of therapies available for the treatment of patients with sarcoma. Some of these recent advances include CDK4 inhibitors and MDM2 inhibitors for patients with liposarcomas and desmoid sarcomas, gamma secretase inhibitors for patients with Kaposi sarcoma, and FGFR and IDH mutations as potential targets in some forms of soft tissue and bone sarcomas. […] Therapies continue to be investigated, including regorafenib (Stivarga), entrectinib (Rozlytrek), and larotrectinib (Vitrakvi), as well as additional therapies, such as cabozantinib (Cabometyx) and immunotherapies, are being explored for the treatment of sarcomas. […] According to Ercolano, while slight improvements in survival have been observed with different types of therapies, like pembrolizumab (Keytruda) or trabectedin (Yondelis), survival rates have only improved by months rather than years.

• #50 New strategies in soft tissue sarcoma treatment | Journal of Hematology & Oncology | Full Text

  https://jhoonline.biomedcentral.com/articles/10.1186/s13045-024-01580-3

  Tazemetostat stands as a paradigm of effective targeted therapy within a specific sarcoma sub-histotype, leading to an exceptional response and the accelerated approval of an epigenetic drug in January 2020 in the USA, specifically for the treatment of adults and adolescents with locally advanced or metastatic ES not eligible for complete resection. […] The role of gamma-secretase in tumor biology takes center stage, and its targeted inhibition, exemplified by nirogacestat, not only addresses the unique challenges posed by desmoid tumors but also contributes to our broader understanding of the intricate interplay between molecular pathways and tumorigenesis.

• #51 New strategies in soft tissue sarcoma treatment | Journal of Hematology & Oncology | Full Text

  https://jhoonline.biomedcentral.com/articles/10.1186/s13045-024-01580-3

  Tazemetostat stands as a paradigm of effective targeted therapy within a specific sarcoma sub-histotype, leading to an exceptional response and the accelerated approval of an epigenetic drug in January 2020 in the USA, specifically for the treatment of adults and adolescents with locally advanced or metastatic ES not eligible for complete resection. […] The role of gamma-secretase in tumor biology takes center stage, and its targeted inhibition, exemplified by nirogacestat, not only addresses the unique challenges posed by desmoid tumors but also contributes to our broader understanding of the intricate interplay between molecular pathways and tumorigenesis.

• #52 Soft Tissue Sarcoma Treatment Protocols: Treatment Protocols

  https://emedicine.medscape.com/article/2007168-overview

  In metastatic disease, it is important to differentiate between limited and disseminated metastases. […] Limited metastasis involves only one organ and should be considered for resection for improved disease-free survival (DFS) and overall survival (OS). […] Patients with limited metastatic disease or recurrent disease after primary therapy should be considered for surgery, radiofrequency ablation (RFA), embolization, or radiation therapy with curative intent. […] In stage IV sarcoma, patients with limited disease should also be considered for resection or other definitive intervention, as this is associated with improved disease-free survival. […] Prevention of local recurrence may require additional radiation and/or chemotherapy. […] Tazemetostat is a first-in-class enhancer of zeste homolog 2 (EZH2) inhibitor indicated for patients aged 16 y or older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection.

• #53 Sarcoma Program | Stanford Health Care

  https://stanfordhealthcare.org/medical-clinics/sarcoma-program.html

  Our medical oncologists are studying new targeted therapy medications to treat various types of sarcoma. […] Surgery is often the first treatment for many types of sarcoma. Our goal is to remove as much of the tumor as possible while preserving healthy tissue. […] We frequently combine surgery with other treatments, such as radiation therapy, chemotherapy, and targeted therapy. […] Stanford Health Care researchers are actively developing new forms of targeted therapy for sarcoma. […] Radiation therapy uses high-energy X-rays to damage or destroy cancer cells. […] Our interventional radiologists deliver cancer treatment directly to the tumor using minimally invasive procedures. […] Our experienced cancer geneticists can identify a tumors unique biomarkers, including genes, proteins, and other substances. […] Our support programs are available to you throughout your diagnosis, treatment, and follow-up care.

• #54 Immunotherapy for Sarcoma – Cancer Research Institute

  https://www.cancerresearch.org/cancer-types/sarcoma

  Immunotherapy for sarcoma has some success cases, including the earliest known instances of spontaneous regression, although sarcoma cancer immunology is still largely unknown. […] Many patients treated with conventional therapies (surgery, chemotherapy, and radiation) will develop advanced, metastatic sarcomas that are resistant to those approaches, so new treatments are needed. […] Surgery is imperative to the treatment of most types of sarcomas, and additional chemotherapy or radiation therapies may be applied before and/or after surgery. In the case of many bone sarcomas, chemotherapy significantly and positively impacts the prognosis for sarcoma patients, though the treatment process is a long and arduous one. […] While effective in some sarcomas, between 25-50% of sarcoma patients treated with conventional methods will still develop metastatic disease. In these cases in which the cancer has spread to other organs, complete responses to chemotherapy are quite rare. Fortunately, immune-based treatments, collectively known as immunotherapy, have helped against other advanced cancers and have begun to show benefits in certain types of advanced sarcoma.

• #55 Immunotherapy for Sarcoma – Cancer Research Institute

  https://www.cancerresearch.org/cancer-types/sarcoma

  Currently, there are three FDA-approved immunotherapy options for patients with sarcoma, and many more are being investigated in clinical trials. […] Several other immunotherapies have shown effectiveness in clinical trials and could become approved for patients in the near future. […] At the Cancer Research Institute, we work to advance immune-based therapies for the treatment of all types of sarcomas. […] CRI has partnered with Stand Up To Cancer (SU2C) to fund a “Dream Team” of researchers working to develop the next frontier of cancer immunotherapy, including an adoptive cellular therapy plus immune checkpoint inhibitor trial for the treatment of NY-ESO-1+ sarcomas. […] Immunomodulators manipulate the “brakes” and “gas pedals” of the immune system. […] Oncolytic virus therapy uses viruses that are often, but not always, modified in order to infect tumor cells and cause them to self-destruct.

• #56 Hard-hitting Therapies for Soft Tissue Cancers: New Treatment Approaches for Sarcomas  – American Association for Cancer Research (AACR)

  https://www.aacr.org/blog/2022/07/11/hard-hitting-therapies-for-soft-tissue-cancers-new-treatment-approaches-for-sarcomas/

  Sarcomas are frequently treated with surgery, which may be the only treatment required for early-stage, low-grade tumors. For more advanced sarcomas, however, additional therapies, such as chemotherapy, radiation, targeted therapy, or immunotherapy may be required. […] One treatment approach under investigation is utilizing immunotherapy to promote antitumor activity by the immune response. […] Clinical responses were observed in approximately 37 percent of patients. […] The researchers concluded that combining TWB2450 with anlotinib was effective against ASPS, suggesting that dual inhibition of immune checkpoint activity and angiogenesis may be a promising treatment strategy for this sarcoma. […] Another clinical trial also demonstrated the potential of immune checkpoint inhibition to treat sarcoma.

• #57 Hard-hitting Therapies for Soft Tissue Cancers: New Treatment Approaches for Sarcomas  – American Association for Cancer Research (AACR)

  https://www.aacr.org/blog/2022/07/11/hard-hitting-therapies-for-soft-tissue-cancers-new-treatment-approaches-for-sarcomas/

  These results suggest that pembrolizumab could be effective for patients with Kaposi sarcoma, although studies in a larger group of patients are needed. […] The authors concluded that lenalidomide could be a viable treatment option for patients with Kaposi sarcoma. […] Due to the antitumor activity observed in this trial, the authors of the study suggested that lurbinectedin could be effective in conjunction with other therapies. […] Based on these results, the authors concluded that cabozantinib in combination with temozolomide showed promise against uterine sarcoma and suggested that the combination be evaluated in a clinical trial. […] Ongoing research will continue to uncover new treatment strategies to improve outcomes for those affected by these cancers.

• #58 Soft Tissue Sarcoma Treatment (PDQ®) – PDQ Cancer Information Summaries – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK65773/

  Treatment of stage IV soft tissue sarcoma may include the following: Chemotherapy. Surgery to remove cancer that has spread to the lungs. Targeted therapy with a tyrosine kinase inhibitor (pazopanib or imatinib). […] Treatment of recurrent soft tissue sarcoma may include the following: Surgery (wide local excision) with or without radiation therapy. Surgery (amputation; rarely done). Surgery to remove cancer that has recurred in the lungs. Targeted therapy with a tyrosine kinase inhibitor (pazopanib or imatinib). Chemotherapy. A clinical trial of an immune checkpoint inhibitor (pembrolizumab, nivolumab, or ipilimumab).

• #59 Soft Tissue Sarcoma Treatment (PDQ®) – PDQ Cancer Information Summaries – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK65773/

  Treatment of stage IV soft tissue sarcoma may include the following: Chemotherapy. Surgery to remove cancer that has spread to the lungs. Targeted therapy with a tyrosine kinase inhibitor (pazopanib or imatinib). […] Treatment of recurrent soft tissue sarcoma may include the following: Surgery (wide local excision) with or without radiation therapy. Surgery (amputation; rarely done). Surgery to remove cancer that has recurred in the lungs. Targeted therapy with a tyrosine kinase inhibitor (pazopanib or imatinib). Chemotherapy. A clinical trial of an immune checkpoint inhibitor (pembrolizumab, nivolumab, or ipilimumab).

• #60 FDA Approves First Engineered Cell Therapy for Treating Rare Sarcoma | Memorial Sloan Kettering Cancer Center

  https://www.mskcc.org/news/immunotherapy-clinical-trial-shows-promise-for-treating-rare-sarcomas

  Dr. Sandra D’Angelo is focused on developing immunotherapy treatments for soft tissue sarcoma. […] The U.S. Food and Drug Administration (FDA) has granted accelerated approval for the immunotherapy afamitresgene autoleuecel (Tecelra, also known as afami-cel) for the treatment of adults with a rare soft tissue cancer called synovial sarcoma. […] This treatment offers an important new option for people with this rare cancer, Dr. DAngelo says. […] Sarcoma in general, and synovial sarcoma in particular, is a type of cancer where more treatments are desperately needed, Dr. DAngelo explains. […] Afami-cel is an engineered cell therapy, similar to the CAR T treatments that have been approved for treating certain blood cancers since 2017. […] The cancer-causing protein that afami-cel targets is called MAGE-A4.

• #61 FDA Approves First Gene Therapy to Treat Adults with Metastatic Synovial Sarcoma | FDA

  https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-treat-adults-metastatic-synovial-sarcoma

  The U.S. Food and Drug Administration approved Tecelra (afamitresgene autoleucel), a gene therapy indicated for the treatment of adults with unresectable or metastatic synovial sarcoma who have received prior chemotherapy, are HLA antigen(s) A*02:01P, -A*02:02P, -A*02:03P, or -A*02:06P positive, and whose tumor expresses the MAGE-A4 antigen as determined by FDA authorized companion diagnostic devices. […] Treatment typically involves surgery to remove the tumor and may also include radiotherapy and/or chemotherapy if the tumor is larger, returns after being removed or has spread beyond its original location. […] Tecelra is also the first FDA-approved T cell receptor (TCR) gene therapy. […] Tecelra was approved using the Accelerated Approval pathway, under which the FDA may approve drugs for serious or life-threatening diseases or conditions where there is an unmet medical need and the drug is shown to have an effect on a surrogate endpoint that is reasonably likely to predict a clinical benefit to patients (improving how patients feel or function, or whether they survive longer).

• #62 FDA Approves First Engineered Cell Therapy for Treating Rare Sarcoma | Memorial Sloan Kettering Cancer Center

  https://www.mskcc.org/news/immunotherapy-clinical-trial-shows-promise-for-treating-rare-sarcomas

  Dr. Sandra D’Angelo is focused on developing immunotherapy treatments for soft tissue sarcoma. […] The U.S. Food and Drug Administration (FDA) has granted accelerated approval for the immunotherapy afamitresgene autoleuecel (Tecelra, also known as afami-cel) for the treatment of adults with a rare soft tissue cancer called synovial sarcoma. […] This treatment offers an important new option for people with this rare cancer, Dr. DAngelo says. […] Sarcoma in general, and synovial sarcoma in particular, is a type of cancer where more treatments are desperately needed, Dr. DAngelo explains. […] Afami-cel is an engineered cell therapy, similar to the CAR T treatments that have been approved for treating certain blood cancers since 2017. […] The cancer-causing protein that afami-cel targets is called MAGE-A4.

• #63 Immunotherapy for Sarcoma – Cancer Research Institute

  https://www.cancerresearch.org/cancer-types/sarcoma

  Currently, there are three FDA-approved immunotherapy options for patients with sarcoma, and many more are being investigated in clinical trials. […] Several other immunotherapies have shown effectiveness in clinical trials and could become approved for patients in the near future. […] At the Cancer Research Institute, we work to advance immune-based therapies for the treatment of all types of sarcomas. […] CRI has partnered with Stand Up To Cancer (SU2C) to fund a “Dream Team” of researchers working to develop the next frontier of cancer immunotherapy, including an adoptive cellular therapy plus immune checkpoint inhibitor trial for the treatment of NY-ESO-1+ sarcomas. […] Immunomodulators manipulate the “brakes” and “gas pedals” of the immune system. […] Oncolytic virus therapy uses viruses that are often, but not always, modified in order to infect tumor cells and cause them to self-destruct.

• #64 Hard-hitting Therapies for Soft Tissue Cancers: New Treatment Approaches for Sarcomas  – American Association for Cancer Research (AACR)

  https://www.aacr.org/blog/2022/07/11/hard-hitting-therapies-for-soft-tissue-cancers-new-treatment-approaches-for-sarcomas/

  Sarcomas are frequently treated with surgery, which may be the only treatment required for early-stage, low-grade tumors. For more advanced sarcomas, however, additional therapies, such as chemotherapy, radiation, targeted therapy, or immunotherapy may be required. […] One treatment approach under investigation is utilizing immunotherapy to promote antitumor activity by the immune response. […] Clinical responses were observed in approximately 37 percent of patients. […] The researchers concluded that combining TWB2450 with anlotinib was effective against ASPS, suggesting that dual inhibition of immune checkpoint activity and angiogenesis may be a promising treatment strategy for this sarcoma. […] Another clinical trial also demonstrated the potential of immune checkpoint inhibition to treat sarcoma.

• #65 New strategies in soft tissue sarcoma treatment | Journal of Hematology & Oncology | Full Text

  https://jhoonline.biomedcentral.com/articles/10.1186/s13045-024-01580-3

  The clinical potential of Mipa was explored in a Phase 1b trial involving patients with advanced sarcomas. […] These promising findings underscore the potential of immunotherapy as a more effective treatment option for certain sarcoma patients when compared to traditional cytotoxic chemotherapy. […] Two ongoing randomized studies are currently exploring novel combinations to further enhance the response rate to PD-1 inhibition in patients with TLS-positive sarcomas. […] The study continues to explore the optimal dosing regimen and extends to investigate potential combinations with other agents like gemcitabine. […] The compelling data from both therapeutic agents emphasize the necessity of routine genomic screening for NTRK fusions in sarcomas to tailor personalized treatment approaches that can significantly improve patient outcomes.

• #66 Sarcoma – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/sarcoma/diagnosis-treatment/drc-20452650

  Immunotherapy for cancer is a treatment with medicine that helps the body’s immune system kill cancer cells. […] Tests can show if a sarcoma is likely to respond to immunotherapy. This treatment might help control a sarcoma that has spread to other parts of the body. […] Ablation is a procedure that applies treatment directly to the cancer cells to harm them. Some types of ablation apply energy to the cancer cells that causes them to heat up. […] Ablation might be used to treat sarcoma when surgery isn’t an option. It also might be used when the cancer spreads to other parts of the body.

• #67

  https://umiamihealth.org/en/treatments-and-services/interventional-radiology/cancer-treatments/sarcoma-treatment

  Sarcoma can cause tumors in your bones or connective tissue in any location throughout your body. In the past, surgery was the only option to remove sarcomas. However, thanks to new technology, a new minimally invasive procedure may destroy sarcoma cells using just a needle. […] Ablation therapy uses extreme heat or cold to destroy sarcoma cells while leaving healthy cells undamaged. The procedure is performed by interventional radiologists, who specialize in using imaging guidance to perform minimally invasive procedures. […] We offer a wide range of sarcoma treatments to help patients receive the care that’s right for them working together with our oncology, radiation oncology and surgical colleagues. Our expert interventional radiologists perform ablation and embolization therapies for sarcomas so that patients who cannot undergo surgery have other treatment options.

• #68 Soft Tissue Sarcoma Treatment Protocols: Treatment Protocols

  https://emedicine.medscape.com/article/2007168-overview

  In metastatic disease, it is important to differentiate between limited and disseminated metastases. […] Limited metastasis involves only one organ and should be considered for resection for improved disease-free survival (DFS) and overall survival (OS). […] Patients with limited metastatic disease or recurrent disease after primary therapy should be considered for surgery, radiofrequency ablation (RFA), embolization, or radiation therapy with curative intent. […] In stage IV sarcoma, patients with limited disease should also be considered for resection or other definitive intervention, as this is associated with improved disease-free survival. […] Prevention of local recurrence may require additional radiation and/or chemotherapy. […] Tazemetostat is a first-in-class enhancer of zeste homolog 2 (EZH2) inhibitor indicated for patients aged 16 y or older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection.

• #69 Soft Tissue Sarcoma: Treatment Introduction | Saint Luke’s Health System

  https://www.saintlukeskc.org/health-library/soft-tissue-sarcoma-treatment-introduction

  There are many treatment choices for soft tissue sarcoma. […] The goal of treatment is to cure the cancer. If a cure isn’t possible, treatment may be used to shrink the cancer or keep it under control. Treatment can also improve your quality of life by helping to control the symptoms of the disease. […] Many kinds of treatment can be used for soft tissue sarcoma. Many times, different combinations of treatment may be used. […] Surgery is the main treatment for most soft tissue sarcomas. The goal of surgery is to remove the whole tumor or as much of it as possible. […] The goal of this treatment is to kill cancer cells using powerful beams of energy from radiation sources such as X-rays. […] Ablation is a type of local treatment that uses extreme heat or extreme cold to kill cancer cells.

• #70 Get Sarcoma Treatment | Cleveland Clinic

  https://my.clevelandclinic.org/services/sarcoma-treatment

  Radiation therapy uses high-energy radiation (usually X-rays), to kill cancer cells in specific areas. […] Cleveland Clinic offers an innovative treatment called hypofractionated radiation therapy for bone and soft tissue sarcomas. […] Sometimes we can destroy a sarcoma by freezing or heating it. We use guided imaging (like a CT scan) for ablation therapy. […] During and after treatment, well help you manage your symptoms and any treatment side effects. Our ongoing follow-up care also includes regular imaging and blood tests to check for signs of new cancer. […] Cleveland Clinics highly skilled sarcoma team is ready to help. Well find the right treatment that matches your unique needs and give you personalized, compassionate care throughout your cancer journey and beyond.

• #71

  https://umiamihealth.org/en/treatments-and-services/interventional-radiology/cancer-treatments/sarcoma-treatment

  You may be a candidate for ablation or embolization therapy if you cannot undergo traditional surgeries due to risk factors like age or other issues. The procedure works best for smaller sarcoma tumors and can be used in many different areas of the body. […] During ablation therapy for sarcomas, you’ll receive general anesthesia to keep you asleep and comfortable. Your interventional radiologist will use image guidance, such as a CT or MRI, to identify sarcoma tumors and guide a needle directly in the tumors. […] Once the needle is in place, it is rapidly heated or cooled. These extreme temperatures destroy the tumor cells around the needle. Your doctor can use this procedure on multiple tumors throughout your body. […] Our interventional radiologists and radiology specialists are experts in a variety of minimally invasive procedures everything from treatments to clear blocked blood vessels to advanced cancer therapies like NanoKnife. […] That means you can get some of today’s most promising advancements through clinical trials. You benefit from the latest developments that are fast-tracked from the lab to the bedside.

• #72

  https://umiamihealth.org/en/treatments-and-services/interventional-radiology/cancer-treatments/sarcoma-treatment

  You may be a candidate for ablation or embolization therapy if you cannot undergo traditional surgeries due to risk factors like age or other issues. The procedure works best for smaller sarcoma tumors and can be used in many different areas of the body. […] During ablation therapy for sarcomas, you’ll receive general anesthesia to keep you asleep and comfortable. Your interventional radiologist will use image guidance, such as a CT or MRI, to identify sarcoma tumors and guide a needle directly in the tumors. […] Once the needle is in place, it is rapidly heated or cooled. These extreme temperatures destroy the tumor cells around the needle. Your doctor can use this procedure on multiple tumors throughout your body. […] Our interventional radiologists and radiology specialists are experts in a variety of minimally invasive procedures everything from treatments to clear blocked blood vessels to advanced cancer therapies like NanoKnife. […] That means you can get some of today’s most promising advancements through clinical trials. You benefit from the latest developments that are fast-tracked from the lab to the bedside.

• #73

  https://umiamihealth.org/en/treatments-and-services/interventional-radiology/cancer-treatments/sarcoma-treatment

  Sarcoma can cause tumors in your bones or connective tissue in any location throughout your body. In the past, surgery was the only option to remove sarcomas. However, thanks to new technology, a new minimally invasive procedure may destroy sarcoma cells using just a needle. […] Ablation therapy uses extreme heat or cold to destroy sarcoma cells while leaving healthy cells undamaged. The procedure is performed by interventional radiologists, who specialize in using imaging guidance to perform minimally invasive procedures. […] We offer a wide range of sarcoma treatments to help patients receive the care that’s right for them working together with our oncology, radiation oncology and surgical colleagues. Our expert interventional radiologists perform ablation and embolization therapies for sarcomas so that patients who cannot undergo surgery have other treatment options.

• #74 Soft Tissue Sarcoma Treatment – NCI

  https://www.cancer.gov/types/soft-tissue-sarcoma/patient/adult-soft-tissue-treatment-pdq

  Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. […] Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. […] Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells. […] Immunotherapy is a treatment that uses the patient’s immune system to fight cancer. […] Treatment for soft tissue sarcoma may cause side effects. […] Patients may want to think about taking part in a clinical trial. […] Treatment of stage I soft tissue sarcoma may include the following: Surgery to remove the tumor, such as Mohs microsurgery for small sarcomas of the skin, wide local excision, or limb-sparing surgery.

• #75 Soft Tissue Sarcoma Treatment – NCI

  https://www.cancer.gov/types/soft-tissue-sarcoma/patient/adult-soft-tissue-treatment-pdq

  Treatment of stage II soft tissue sarcoma and stage III soft tissue sarcoma that has not spread to lymph nodes may include the following: Surgery to remove the tumor, such as wide local excision or limb-sparing surgery. […] Treatment of stage III soft tissue sarcoma that has spread to lymph nodes (advanced) may include the following: Surgery (wide local excision) with lymphadenectomy. […] Treatment of stage IV soft tissue sarcoma may include the following: Chemotherapy. Surgery to remove cancer that has spread to the lungs. Targeted therapy with a tyrosine kinase inhibitor (pazopanib or imatinib). […] Treatment of recurrent soft tissue sarcoma may include the following: Surgery (wide local excision) with or without radiation therapy.

• #76 Treatment of Soft Tissue Sarcomas, by Stage | American Cancer Society

  https://www.cancer.org/cancer/types/soft-tissue-sarcoma/treating/by-stage.html

  For all stage II and III sarcomas, removing the tumor with surgery is the main treatment. Lymph nodes will also be removed if they might contain cancer. Radiation may be given after surgery. […] For people whose primary tumor and all metastases cannot be removed completely by surgery, radiation therapy and/or chemotherapy are often used. The chemo drugs doxorubicin and ifosfamide are often the first choice either together or along with other drugs. […] For some types of soft tissue sarcomas, treatment with newer targeted drugs or immunotherapy might also be an option. […] If the sarcoma comes back in the same area where it started, it may be treated with surgery. Radiation therapy may be given after surgery, especially if radiation wasn’t part of the treatment of the original tumor. If external beam radiation was used before, brachytherapy may still be an option. […] If the sarcoma returns in a distant part of the body, chemo, targeted therapy, or immunotherapy drugs may be options.

• #77 Soft Tissue Sarcoma Treatment – NCI

  https://www.cancer.gov/types/soft-tissue-sarcoma/patient/adult-soft-tissue-treatment-pdq

  Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. […] Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. […] Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells. […] Immunotherapy is a treatment that uses the patient’s immune system to fight cancer. […] Treatment for soft tissue sarcoma may cause side effects. […] Patients may want to think about taking part in a clinical trial. […] Treatment of stage I soft tissue sarcoma may include the following: Surgery to remove the tumor, such as Mohs microsurgery for small sarcomas of the skin, wide local excision, or limb-sparing surgery.

• #78 Sarcoma Treatment Options – Virginia Oncology

  https://www.virginiacancer.com/sarcoma/treatment-options/

  Stage I Sarcoma: Surgery (wide local excision, limb-sparing surgery, or Mohs microsurgery). Radiation therapy before and/or after surgery. […] Stages II and III adult soft tissue sarcoma treatments include: Surgery (wide local excision). Surgery (wide local excision) with radiation therapy, for large tumors. High-dose radiation therapy for tumors that cannot be removed by surgery. […] Stage IV adult soft tissue sarcoma: If the disease has spread to the lymph nodes, treatment may include the following treatments: Surgery (wide local excision) with or without lymphadenectomy. Radiation therapy may also be given after surgery. […] Treatment for recurrent adult soft tissue sarcoma may be somewhat different and will be guided by your cancer treatment team of physicians and nurses.

• #79 Soft Tissue Sarcoma Treatment – NCI

  https://www.cancer.gov/types/soft-tissue-sarcoma/patient/adult-soft-tissue-treatment-pdq

  Treatment of stage II soft tissue sarcoma and stage III soft tissue sarcoma that has not spread to lymph nodes may include the following: Surgery to remove the tumor, such as wide local excision or limb-sparing surgery. […] Treatment of stage III soft tissue sarcoma that has spread to lymph nodes (advanced) may include the following: Surgery (wide local excision) with lymphadenectomy. […] Treatment of stage IV soft tissue sarcoma may include the following: Chemotherapy. Surgery to remove cancer that has spread to the lungs. Targeted therapy with a tyrosine kinase inhibitor (pazopanib or imatinib). […] Treatment of recurrent soft tissue sarcoma may include the following: Surgery (wide local excision) with or without radiation therapy.

• #80 Sarcoma Treatment Options – Virginia Oncology

  https://www.virginiacancer.com/sarcoma/treatment-options/

  Stage I Sarcoma: Surgery (wide local excision, limb-sparing surgery, or Mohs microsurgery). Radiation therapy before and/or after surgery. […] Stages II and III adult soft tissue sarcoma treatments include: Surgery (wide local excision). Surgery (wide local excision) with radiation therapy, for large tumors. High-dose radiation therapy for tumors that cannot be removed by surgery. […] Stage IV adult soft tissue sarcoma: If the disease has spread to the lymph nodes, treatment may include the following treatments: Surgery (wide local excision) with or without lymphadenectomy. Radiation therapy may also be given after surgery. […] Treatment for recurrent adult soft tissue sarcoma may be somewhat different and will be guided by your cancer treatment team of physicians and nurses.

• #81 Sarcoma Treatment Options – Blue Ridge Cancer Care

  https://blueridgecancercare.com/disease-drug-information/types-of-cancer/sarcoma/treatment-options/

  For each stage of soft tissue sarcoma, there are different treatment options available. Some of the options that may be offered by your doctor are as follows: […] Stage I Sarcoma: Surgery (wide local excision or Mohs microsurgery). Radiation therapy before and/or after surgery. […] If cancer is found in the head, neck, abdomen, or chest, treatment may include the following: Surgery. Radiation therapy before or after surgery. Fast neutron radiation therapy. […] Stages II and III adult soft tissue sarcoma treatments include: Surgery (wide local excision). Surgery (wide local excision) with radiation therapy, for large tumors. High-dose radiation therapy for tumors that cannot be removed by surgery. Radiation therapy or chemotherapy before limb-sparing surgery. Radiation therapy may also be given after surgery. A clinical trial of surgery followed by chemotherapy, for large tumors.

• #82 Soft Tissue Sarcoma Treatment – NCI

  https://www.cancer.gov/types/soft-tissue-sarcoma/patient/adult-soft-tissue-treatment-pdq

  Treatment of stage II soft tissue sarcoma and stage III soft tissue sarcoma that has not spread to lymph nodes may include the following: Surgery to remove the tumor, such as wide local excision or limb-sparing surgery. […] Treatment of stage III soft tissue sarcoma that has spread to lymph nodes (advanced) may include the following: Surgery (wide local excision) with lymphadenectomy. […] Treatment of stage IV soft tissue sarcoma may include the following: Chemotherapy. Surgery to remove cancer that has spread to the lungs. Targeted therapy with a tyrosine kinase inhibitor (pazopanib or imatinib). […] Treatment of recurrent soft tissue sarcoma may include the following: Surgery (wide local excision) with or without radiation therapy.

• #83 Sarcoma Treatment Options – Blue Ridge Cancer Care

  https://blueridgecancercare.com/disease-drug-information/types-of-cancer/sarcoma/treatment-options/

  Stage IV adult soft tissue sarcoma that involves lymph nodes may include the following treatments: Surgery (wide local excision) with or without lymphadenectomy. Radiation therapy may also be given after surgery. Radiation therapy before and after surgery. A clinical trial of surgery followed by chemotherapy. […] Treatment of stage IV adult soft tissue sarcoma that involves internal organs of the body may include the following: Surgery (wide local excision). Surgery to remove as much of the tumor as possible, followed by radiation therapy. High-dose radiation therapy, with or without chemotherapy, for tumors that cannot be removed by surgery. Chemotherapy with 1 or more anticancer drugs, before surgery or as palliative therapy to relieve symptoms and improve the quality of life. A clinical trial of chemotherapy with or without stem cell transplant. A clinical trial of chemotherapy following surgery to remove cancer that has spread to the lungs. […] Treatment for recurring sarcoma may be somewhat different and will be guided by your cancer treatment team of physicians and nurses.

• #84 Soft Tissue Sarcoma Treatment – NCI

  https://www.cancer.gov/types/soft-tissue-sarcoma/patient/adult-soft-tissue-treatment-pdq

  Treatment of stage II soft tissue sarcoma and stage III soft tissue sarcoma that has not spread to lymph nodes may include the following: Surgery to remove the tumor, such as wide local excision or limb-sparing surgery. […] Treatment of stage III soft tissue sarcoma that has spread to lymph nodes (advanced) may include the following: Surgery (wide local excision) with lymphadenectomy. […] Treatment of stage IV soft tissue sarcoma may include the following: Chemotherapy. Surgery to remove cancer that has spread to the lungs. Targeted therapy with a tyrosine kinase inhibitor (pazopanib or imatinib). […] Treatment of recurrent soft tissue sarcoma may include the following: Surgery (wide local excision) with or without radiation therapy.

• #85 Soft Tissue Sarcoma Treatment (PDQ®) – PDQ Cancer Information Summaries – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK65773/

  Treatment of stage IV soft tissue sarcoma may include the following: Chemotherapy. Surgery to remove cancer that has spread to the lungs. Targeted therapy with a tyrosine kinase inhibitor (pazopanib or imatinib). […] Treatment of recurrent soft tissue sarcoma may include the following: Surgery (wide local excision) with or without radiation therapy. Surgery (amputation; rarely done). Surgery to remove cancer that has recurred in the lungs. Targeted therapy with a tyrosine kinase inhibitor (pazopanib or imatinib). Chemotherapy. A clinical trial of an immune checkpoint inhibitor (pembrolizumab, nivolumab, or ipilimumab).

• #86 Sarcoma Treatment Options – Blue Ridge Cancer Care

  https://blueridgecancercare.com/disease-drug-information/types-of-cancer/sarcoma/treatment-options/

  Stage IV adult soft tissue sarcoma that involves lymph nodes may include the following treatments: Surgery (wide local excision) with or without lymphadenectomy. Radiation therapy may also be given after surgery. Radiation therapy before and after surgery. A clinical trial of surgery followed by chemotherapy. […] Treatment of stage IV adult soft tissue sarcoma that involves internal organs of the body may include the following: Surgery (wide local excision). Surgery to remove as much of the tumor as possible, followed by radiation therapy. High-dose radiation therapy, with or without chemotherapy, for tumors that cannot be removed by surgery. Chemotherapy with 1 or more anticancer drugs, before surgery or as palliative therapy to relieve symptoms and improve the quality of life. A clinical trial of chemotherapy with or without stem cell transplant. A clinical trial of chemotherapy following surgery to remove cancer that has spread to the lungs. […] Treatment for recurring sarcoma may be somewhat different and will be guided by your cancer treatment team of physicians and nurses.

• #87 Soft Tissue Sarcoma Treatment – NCI

  https://www.cancer.gov/types/soft-tissue-sarcoma/patient/adult-soft-tissue-treatment-pdq

  Treatment of stage II soft tissue sarcoma and stage III soft tissue sarcoma that has not spread to lymph nodes may include the following: Surgery to remove the tumor, such as wide local excision or limb-sparing surgery. […] Treatment of stage III soft tissue sarcoma that has spread to lymph nodes (advanced) may include the following: Surgery (wide local excision) with lymphadenectomy. […] Treatment of stage IV soft tissue sarcoma may include the following: Chemotherapy. Surgery to remove cancer that has spread to the lungs. Targeted therapy with a tyrosine kinase inhibitor (pazopanib or imatinib). […] Treatment of recurrent soft tissue sarcoma may include the following: Surgery (wide local excision) with or without radiation therapy.

• #88 Soft Tissue Sarcoma Treatment (PDQ®) – PDQ Cancer Information Summaries – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK65773/

  Treatment of stage IV soft tissue sarcoma may include the following: Chemotherapy. Surgery to remove cancer that has spread to the lungs. Targeted therapy with a tyrosine kinase inhibitor (pazopanib or imatinib). […] Treatment of recurrent soft tissue sarcoma may include the following: Surgery (wide local excision) with or without radiation therapy. Surgery (amputation; rarely done). Surgery to remove cancer that has recurred in the lungs. Targeted therapy with a tyrosine kinase inhibitor (pazopanib or imatinib). Chemotherapy. A clinical trial of an immune checkpoint inhibitor (pembrolizumab, nivolumab, or ipilimumab).

• #89 Treatment of Soft Tissue Sarcomas, by Stage | American Cancer Society

  https://www.cancer.org/cancer/types/soft-tissue-sarcoma/treating/by-stage.html

  For all stage II and III sarcomas, removing the tumor with surgery is the main treatment. Lymph nodes will also be removed if they might contain cancer. Radiation may be given after surgery. […] For people whose primary tumor and all metastases cannot be removed completely by surgery, radiation therapy and/or chemotherapy are often used. The chemo drugs doxorubicin and ifosfamide are often the first choice either together or along with other drugs. […] For some types of soft tissue sarcomas, treatment with newer targeted drugs or immunotherapy might also be an option. […] If the sarcoma comes back in the same area where it started, it may be treated with surgery. Radiation therapy may be given after surgery, especially if radiation wasn’t part of the treatment of the original tumor. If external beam radiation was used before, brachytherapy may still be an option. […] If the sarcoma returns in a distant part of the body, chemo, targeted therapy, or immunotherapy drugs may be options.

• #90 Synovial Sarcoma Treatment & Management: Approach Considerations, Chemotherapy, Surgical Therapy

  https://emedicine.medscape.com/article/1257131-treatment

  There are no contraindications for surgical treatment of synovial sarcoma (also referred to as synovial cell sarcoma), which is potentially life-saving. There is a relative contraindication for treating these patients in primary centers. Early referral to tertiary centers for definitive treatment must be preferred. Ideally, treatment should be performed by a multidisciplinary team with personnel experienced in the management of soft-tissue sarcomas. […] Adjuvant chemotherapy and neoadjuvant chemotherapy have been proposed for patients with metastatic soft-tissue sarcomas. Although chemotherapy in the treatment of synovial sarcoma has been controversial, some studies have shown overall survival benefits in selected patients. […] Ladenstein et al reported improved survival rates with the use of adjuvant doxorubicin- and cyclophosphamide-based chemotherapy.

• #91 Synovial Sarcoma Treatment & Management: Approach Considerations, Chemotherapy, Surgical Therapy

  https://emedicine.medscape.com/article/1257131-treatment

  There are no contraindications for surgical treatment of synovial sarcoma (also referred to as synovial cell sarcoma), which is potentially life-saving. There is a relative contraindication for treating these patients in primary centers. Early referral to tertiary centers for definitive treatment must be preferred. Ideally, treatment should be performed by a multidisciplinary team with personnel experienced in the management of soft-tissue sarcomas. […] Adjuvant chemotherapy and neoadjuvant chemotherapy have been proposed for patients with metastatic soft-tissue sarcomas. Although chemotherapy in the treatment of synovial sarcoma has been controversial, some studies have shown overall survival benefits in selected patients. […] Ladenstein et al reported improved survival rates with the use of adjuvant doxorubicin- and cyclophosphamide-based chemotherapy.

• #92 Synovial Sarcoma Treatment & Management: Approach Considerations, Chemotherapy, Surgical Therapy

  https://emedicine.medscape.com/article/1257131-treatment

  Chemotherapy should be considered in patients with extremity tumors larger than 5 cm. […] The efficacy of chemotherapy as adjuvant treatment after surgery has been a controversial aspect of treatment of synovial sarcoma. Chemotherapy has not proved to provide a significant benefit in survival rates in all series. […] However, a retrospective analysis of 271 patients with synovial sarcoma, of whom 41% received adjuvant chemotherapy, found that the 5-year metastasis-free survival (MFS) rate was 60% for those who were treated with chemotherapy and 48% for those who were not. […] Surgical excision is still the cornerstone of treatment for synovial sarcoma. A tumor-free margin of 1-3 cm is recommended. […] Even with microscopically negative margins, patients could develop local recurrence.

• #93 FDA Approves First Gene Therapy to Treat Adults with Metastatic Synovial Sarcoma | FDA

  https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-treat-adults-metastatic-synovial-sarcoma

  The U.S. Food and Drug Administration approved Tecelra (afamitresgene autoleucel), a gene therapy indicated for the treatment of adults with unresectable or metastatic synovial sarcoma who have received prior chemotherapy, are HLA antigen(s) A*02:01P, -A*02:02P, -A*02:03P, or -A*02:06P positive, and whose tumor expresses the MAGE-A4 antigen as determined by FDA authorized companion diagnostic devices. […] Treatment typically involves surgery to remove the tumor and may also include radiotherapy and/or chemotherapy if the tumor is larger, returns after being removed or has spread beyond its original location. […] Tecelra is also the first FDA-approved T cell receptor (TCR) gene therapy. […] Tecelra was approved using the Accelerated Approval pathway, under which the FDA may approve drugs for serious or life-threatening diseases or conditions where there is an unmet medical need and the drug is shown to have an effect on a surrogate endpoint that is reasonably likely to predict a clinical benefit to patients (improving how patients feel or function, or whether they survive longer).

• #94 Soft Tissue Sarcoma Treatment (PDQ®): Treatment – Health Professional Information [NCI] | Kaiser Permanente

  https://healthy.kaiserpermanente.org/health-wellness/health-encyclopedia/he.soft-tissue-sarcoma-treatment-pdq%C2%AE-treatment-health-professional-information-nci.ncicdr0000062820

  Neoadjuvant chemotherapy with or without radiation therapy has shown response rates of 17% to 32%, 10-year RFS rates of up to 58%, and 10-year OS rates of up to 64%. […] Anthracyclines remain the first-line class of systemic therapy in managing most locally advanced and metastatic soft tissue sarcoma. […] The clinical benefit of adding other drugs to the single-agent doxorubicin regimen is controversial. […] The U.S. Food and Drug Administration (FDA) has approved eribulin, trabectedin, and pazopanib for the treatment of soft tissue sarcomas after failure of a first-line chemotherapy regimen. […] Patients who develop a local recurrence can often be treated with local therapy, such as surgical excision plus radiation therapy (after previous minimal therapy) or amputation (after previous aggressive treatment).

• #95 Advances in the Treatment of Sarcomas

  https://www.targetedonc.com/view/advances-in-the-treatment-of-sarcomas

  Lisa B. Ercolano, MD, discusses some of the advances that have been seen in the treatment of sarcomas. […] Over the past few years, there has been an increase in the number of therapies available for the treatment of patients with sarcoma. Some of these recent advances include CDK4 inhibitors and MDM2 inhibitors for patients with liposarcomas and desmoid sarcomas, gamma secretase inhibitors for patients with Kaposi sarcoma, and FGFR and IDH mutations as potential targets in some forms of soft tissue and bone sarcomas. […] Therapies continue to be investigated, including regorafenib (Stivarga), entrectinib (Rozlytrek), and larotrectinib (Vitrakvi), as well as additional therapies, such as cabozantinib (Cabometyx) and immunotherapies, are being explored for the treatment of sarcomas. […] According to Ercolano, while slight improvements in survival have been observed with different types of therapies, like pembrolizumab (Keytruda) or trabectedin (Yondelis), survival rates have only improved by months rather than years.

• #96 Soft tissue sarcoma | Macmillan Cancer Support

  https://www.macmillan.org.uk/cancer-information-and-support/soft-tissue-sarcoma

  Radiotherapy uses high-energy rays to destroy cancer cells. Radiotherapy may be given before surgery to shrink the cancer, or after surgery, to destroy any remaining cancer cells. It can also be used to relieve symptoms and control sarcoma that has spread or come back. Rarely, when surgery is not possible, it is used on its own. […] Chemotherapy uses anti-cancer (cytotoxic) drugs to destroy cancer cells. Not everyone has chemotherapy. It depends on the type of sarcoma and the risk of it coming back. It may be given after or before surgery. Chemotherapy can also be given to relieve symptoms and to control sarcoma that cannot be completely removed or has spread. […] Targeted therapy uses drugs to find and attack cancer cells. There are different types of targeted therapy, including tyrosine kinase inhibitors (TKIs). Imatinib is a TKI that is often used to treat gastrointestinal stromal tumour (GIST). Some other targeted therapy drugs might be used in some situations to help to control soft tissue sarcoma.

• #97 Treatment options | Soft tissue sarcoma | Cancer Research UK

  https://www.cancerresearchuk.org/about-cancer/soft-tissue-sarcoma/treatment/treatment-options-for-soft-tissue-sarcoma

  Some people might have chemotherapy before surgery. This is called neoadjuvant chemotherapy. It aims to shrink the cancer and make it easier to remove with surgery. […] People with gastrointestinal stromal tumours (GISTs) that have spread might have a drug called imatinib (Glivec). Imatinib can work very well at controlling the growth of GISTs for several years or more. […] Surgery is the main treatment and it might cure you. Your surgeon aims to remove the cancer and a border of healthy tissue around it. […] You may have radiotherapy before surgery, mostly for large, deep and high grade sarcomas. […] Radiotherapy or chemotherapy (or a combination of both) aims to help keep the cancer under control for longer. And to relieve symptoms. […] Your doctor might ask if youd like to take part in a clinical trial. Doctors and researchers do trials to make existing treatments better and develop new treatments. […] The main treatment for soft tissue sarcoma is surgery. You may also have radiotherapy treatment to reduce the symptoms and help you feel better. A team of doctors and other professionals discuss the best treatment and care for you.

• #98 Sarcoma Treatment | Baptist Health Miami Cancer Institute

  https://baptisthealth.net/services/cancer-care/miami-cancer-institute/our-approach/adult-cancers/soft-tissue-sarcoma/treatment

  Every patient at Miami Cancer Institute receives a personalized treatment plan put together by our team of medical oncologists, surgical oncologists, radiation oncologists and interventional oncologists. […] Surgery is part of our treatment for sarcoma or soft tissue tumors. During surgery, we will remove the tumor and may also remove some surrounding tissue, bone and lymph nodes. […] Radiation is often used alongside surgery to treat sarcoma. […] Although chemotherapy drugs are used less often in treating sarcoma, your care team may decide to use medicines, such as Adriamycin or Ifosfamide, depending on the type and stage of sarcoma you have. […] Interventional oncologists use minimally invasive, image-guided techniques to treat your soft tissue sarcoma. […] Depending on the stage and size of your cancer, your care team may also choose to use targeted therapies, such as imatinib (Gleevec) for treating GIST, and olaratumab for treating liposarcoma and leiomyosarcoma. […] Miami Cancer Institute oncologists also have access to new immunotherapy treatments for sarcoma, which use medicines that stimulate an immune response to destroy cancer cells.

• #99 Current treatment of soft tissue sarcoma

  https://pmc.ncbi.nlm.nih.gov/articles/PMC2566912/

  The goal of curative surgical excision is en bloc excision of the tumor and any biopsy tracts with a negative margin of normal tissue of 1 to 2 cm. […] Amputation is now reserved for the small proportion of patients with massive tumors, extensive involvement of the neurovascular bundle, and nonfunctional limbs at presentation. […] Chemotherapy has poor results in treating sarcoma. The role of adjuvant chemotherapy remains controversial because of the absence of convincing level 1 evidence that it improves overall survival. […] Neoadjuvant chemotherapy is indicated in the treatment of rhabdomyosarcoma because, unlike most sarcomas, high response rates are seen in this subtype. […] Radiation can be an effective treatment to decrease local recurrence of soft tissue sarcomas. […] The current National Comprehensive Cancer Network guidelines recommend radiation therapy for extremity sarcomas for high-grade lesions, low-grade lesions 5 cm, or positive margins. […] While advances have been made, the treatment of soft tissue sarcoma still has much room for improvement.

• #100 Current treatment of soft tissue sarcoma

  https://pmc.ncbi.nlm.nih.gov/articles/PMC2566912/

  The goal of curative surgical excision is en bloc excision of the tumor and any biopsy tracts with a negative margin of normal tissue of 1 to 2 cm. […] Amputation is now reserved for the small proportion of patients with massive tumors, extensive involvement of the neurovascular bundle, and nonfunctional limbs at presentation. […] Chemotherapy has poor results in treating sarcoma. The role of adjuvant chemotherapy remains controversial because of the absence of convincing level 1 evidence that it improves overall survival. […] Neoadjuvant chemotherapy is indicated in the treatment of rhabdomyosarcoma because, unlike most sarcomas, high response rates are seen in this subtype. […] Radiation can be an effective treatment to decrease local recurrence of soft tissue sarcomas. […] The current National Comprehensive Cancer Network guidelines recommend radiation therapy for extremity sarcomas for high-grade lesions, low-grade lesions 5 cm, or positive margins. […] While advances have been made, the treatment of soft tissue sarcoma still has much room for improvement.

• #101 Treatment options | Cancer Australia

  https://www.canceraustralia.gov.au/cancer-types/sarcoma/treatment-options

  Sarcoma treatment depends on the cancer type, location, spread, general health, and personal preferences, and may include surgery, chemotherapy, radiation therapy, or targeted therapy. […] Treatment options can include surgery, chemotherapy, radiation therapy and targeted therapy. […] Surgery is the most common treatment for soft tissue sarcoma and gastrointestinal stromal tumours in adults. The goal is to remove the entire tumour. […] Along with surgery, some people may receive chemotherapy. […] Chemotherapy is part of the treatment for almost all patients with Ewing sarcoma. […] Along with surgery, some people may receive radiation therapy. […] Targeted therapy aims to destroy sarcoma cells while doing little damage to normal cells. […] For soft tissue sarcoma, treatment of recurrent disease might involve surgery, chemotherapy, targeted therapy or radiation therapy. […] Treatment of recurrent gastrointestinal stromal tumours (GIST) might involve further surgery or targeted therapy.

• #102

  https://winshipcancer.emory.edu/cancer-types-and-treatments/sarcoma/treatment.php

  Radiation plays a key role in sarcoma treatment guidelines. […] Radiation is administered for many soft tissue sarcomas, and is an integral component in the management of patients with soft tissue sarcomas of the extremity and trunk. […] Proton therapy is often used in the treatment of chordomas and chondrosarcomas, as well as many other types of soft tissue sarcomas. […] Immunotherapies, which involve the use of medications to enhance the body’s natural defenses to target and attack specific types of cancer cells, have been highly effective in treating certain solid cancers and leukemias. […] In addition to these sarcoma treatment guidelines, participating in clinical trials may be an option. […] Clinical trials provide patients access to new medications that are being developed to treat sarcoma. […] In addition to advanced sarcoma treatment options, Winship also offers a supportive oncology team of specialized doctors and nurses who can help with the physical, psychological and emotional aspects of living with cancer, including symptom management and counseling.

• #103 Soft Tissue Sarcoma Treatment Protocols: Treatment Protocols

  https://emedicine.medscape.com/article/2007168-overview

  A phase II study randomized patients with leiomyosarcomas to gemcitabine (1200 mg/m2 IV on days 1 and 8; every 21 d) alone or gemcitabine (900 mg/m2 IV over 90 min on days 1 and 8) and docetaxel (100 mg/m2 IV over 90 min on day 8; every 21 d) and reported higher response rates in the dual chemotherapy arm (32% vs 27%), with a 3% complete response (CR) rate and significantly longer progression-free survival (6.3 vs 3 mo). […] Treatment is wide excision and irradiation; however, angiosarcoma is highly aggressive and has a propensity for local recurrence, multifocal spread, and early hematogenous dissemination. […] Chemosensitive disease with particular sensitivity to ifosfamide.

• #104 Soft Tissue Sarcoma Treatment Protocols: Treatment Protocols

  https://emedicine.medscape.com/article/2007168-overview

  A phase II study randomized patients with leiomyosarcomas to gemcitabine (1200 mg/m2 IV on days 1 and 8; every 21 d) alone or gemcitabine (900 mg/m2 IV over 90 min on days 1 and 8) and docetaxel (100 mg/m2 IV over 90 min on day 8; every 21 d) and reported higher response rates in the dual chemotherapy arm (32% vs 27%), with a 3% complete response (CR) rate and significantly longer progression-free survival (6.3 vs 3 mo). […] Treatment is wide excision and irradiation; however, angiosarcoma is highly aggressive and has a propensity for local recurrence, multifocal spread, and early hematogenous dissemination. […] Chemosensitive disease with particular sensitivity to ifosfamide.

• #105 Treating Soft Tissue Sarcomas | Soft Tissue Sarcoma Treatments | American Cancer Society

  https://www.cancer.org/cancer/types/soft-tissue-sarcoma/treating.html

  Clinical trials are carefully controlled research studies that are done to get a closer look at promising new treatments or procedures. Clinical trials are one way to get state-of-the-art cancer treatment. […] You may hear about alternative or complementary methods to relieve symptoms or treat your cancer that your doctors havent mentioned. […] Be sure to talk to your cancer care team about any method you are thinking about using. They can help you learn what is known (or not known) about the method, which can help you make an informed decision. […] Whether you are thinking about treatment, getting treatment, or not being treated at all, you can still get supportive care to help with pain or other symptoms. […] For some people, when treatments have been tried and are no longer controlling the cancer, it could be time to weigh the benefits and risks of continuing to try new treatments. […] Remember that even if you choose not to treat the cancer, you can still get supportive care to help with pain or other symptoms.

• #106 New strategies in soft tissue sarcoma treatment | Journal of Hematology & Oncology | Full Text

  https://jhoonline.biomedcentral.com/articles/10.1186/s13045-024-01580-3

  The standard first-line treatment for these cancers involves anthracycline-based regimens, which are used across nearly all subtypes and result in a median progression-free survival (mPFS) of approximately six months. Upon disease progression, second-line treatments such as gemcitabine, dacarbazine, ifosfamide, eribulin, and pazopanib are selected based on tumor histotype, contributing to an average median overall survival (mOS) of 20 months. […] This review aims to provide a comprehensive overview of the latest advancements in systemic therapies for STS, including chemotherapies, targeted agents, and immunotherapies, with the ultimate goal of enhancing patient survival. […] The innovative aspect of ADCs lies in their ability to exploit the natural properties of antibodies to seek out and bind to specific antigens expressed on the surface of cancer cells.

• #107 New strategies in soft tissue sarcoma treatment | Journal of Hematology & Oncology | Full Text

  https://jhoonline.biomedcentral.com/articles/10.1186/s13045-024-01580-3

  The clinical potential of Mipa was explored in a Phase 1b trial involving patients with advanced sarcomas. […] These promising findings underscore the potential of immunotherapy as a more effective treatment option for certain sarcoma patients when compared to traditional cytotoxic chemotherapy. […] Two ongoing randomized studies are currently exploring novel combinations to further enhance the response rate to PD-1 inhibition in patients with TLS-positive sarcomas. […] The study continues to explore the optimal dosing regimen and extends to investigate potential combinations with other agents like gemcitabine. […] The compelling data from both therapeutic agents emphasize the necessity of routine genomic screening for NTRK fusions in sarcomas to tailor personalized treatment approaches that can significantly improve patient outcomes.

• #108 A new treatment for sarcoma extracted from combination of miRNA deregulation and gene association rules | Signal Transduction and Targeted Therapy

  https://www.nature.com/articles/s41392-023-01470-z

  Sarcomas are a group of heterogeneous mesodermic rare tumors with high incidence in children, reaching up to 20% of neoplasms. Standard treatment for sarcomas is surgical resection, and only some patients are treated with chemotherapy and/or radiation therapy. The 5-year relative survival rate for patients with metastatic sarcoma is only 15%. Therefore, new treatments are required to increase the survival of these patients. […] Here, we analyzed changes in miRNA expression in sarcoma. With in-depth bioinformatics analysis, the use of association rules, and reported gene-drug associations, we established a new flow chart for treatment analysis, identifying several potential new treatments for sarcoma patients. […] To choose possible treatments, we used the GSE21050 sarcoma dataset, which contains data on gene expression, metastases, and survival data.

• #109 A new treatment for sarcoma extracted from combination of miRNA deregulation and gene association rules | Signal Transduction and Targeted Therapy

  https://www.nature.com/articles/s41392-023-01470-z

  We found that the combination of citalopram (related to CREB1 expression) and cisplatin, two drugs that are not currently used to treat sarcomas, showed some efficacy in vitro and in vivo. The same happened when we combined vemurafenib with citalopram. […] Here, we present a new approach for identifying treatment combinations for sarcoma. We demonstrate that identifying a list of common downregulated miRNAs in sarcoma can be used to design potential treatments. These miRNAs regulate, in a complex network of multiple nodes, a wide set of genes, many of which are commonly dysregulated in sarcoma. Gene Ontology analysis suggests an increase in metastasis. Therefore, the relationship of the miRNAs with their targets allowed us to identify biomarkers of metastases. We identified AKT3, CREB1, and PAK2 as potential biomarkers for sarcoma metastasis, designing new individual or combined treatments, with drugs related to each gene. […] We also identified high number of association rules between citalopram-related genes and 5-FU and paclitaxel-related genes, suggesting that, although not common in sarcoma, these combinations should be tested.

• #110 New strategies in soft tissue sarcoma treatment | Journal of Hematology & Oncology | Full Text

  https://jhoonline.biomedcentral.com/articles/10.1186/s13045-024-01580-3

  The clinical potential of Mipa was explored in a Phase 1b trial involving patients with advanced sarcomas. […] These promising findings underscore the potential of immunotherapy as a more effective treatment option for certain sarcoma patients when compared to traditional cytotoxic chemotherapy. […] Two ongoing randomized studies are currently exploring novel combinations to further enhance the response rate to PD-1 inhibition in patients with TLS-positive sarcomas. […] The study continues to explore the optimal dosing regimen and extends to investigate potential combinations with other agents like gemcitabine. […] The compelling data from both therapeutic agents emphasize the necessity of routine genomic screening for NTRK fusions in sarcomas to tailor personalized treatment approaches that can significantly improve patient outcomes.

• #111 Hard-hitting Therapies for Soft Tissue Cancers: New Treatment Approaches for Sarcomas  – American Association for Cancer Research (AACR)

  https://www.aacr.org/blog/2022/07/11/hard-hitting-therapies-for-soft-tissue-cancers-new-treatment-approaches-for-sarcomas/

  Sarcomas are frequently treated with surgery, which may be the only treatment required for early-stage, low-grade tumors. For more advanced sarcomas, however, additional therapies, such as chemotherapy, radiation, targeted therapy, or immunotherapy may be required. […] One treatment approach under investigation is utilizing immunotherapy to promote antitumor activity by the immune response. […] Clinical responses were observed in approximately 37 percent of patients. […] The researchers concluded that combining TWB2450 with anlotinib was effective against ASPS, suggesting that dual inhibition of immune checkpoint activity and angiogenesis may be a promising treatment strategy for this sarcoma. […] Another clinical trial also demonstrated the potential of immune checkpoint inhibition to treat sarcoma.

• #112 A new treatment for sarcoma extracted from combination of miRNA deregulation and gene association rules | Signal Transduction and Targeted Therapy

  https://www.nature.com/articles/s41392-023-01470-z

  We found that the combination of citalopram (related to CREB1 expression) and cisplatin, two drugs that are not currently used to treat sarcomas, showed some efficacy in vitro and in vivo. The same happened when we combined vemurafenib with citalopram. […] Here, we present a new approach for identifying treatment combinations for sarcoma. We demonstrate that identifying a list of common downregulated miRNAs in sarcoma can be used to design potential treatments. These miRNAs regulate, in a complex network of multiple nodes, a wide set of genes, many of which are commonly dysregulated in sarcoma. Gene Ontology analysis suggests an increase in metastasis. Therefore, the relationship of the miRNAs with their targets allowed us to identify biomarkers of metastases. We identified AKT3, CREB1, and PAK2 as potential biomarkers for sarcoma metastasis, designing new individual or combined treatments, with drugs related to each gene. […] We also identified high number of association rules between citalopram-related genes and 5-FU and paclitaxel-related genes, suggesting that, although not common in sarcoma, these combinations should be tested.

• #113 Treating Soft Tissue Sarcomas | Soft Tissue Sarcoma Treatments | American Cancer Society

  https://www.cancer.org/cancer/types/soft-tissue-sarcoma/treating.html

  Clinical trials are carefully controlled research studies that are done to get a closer look at promising new treatments or procedures. Clinical trials are one way to get state-of-the-art cancer treatment. […] You may hear about alternative or complementary methods to relieve symptoms or treat your cancer that your doctors havent mentioned. […] Be sure to talk to your cancer care team about any method you are thinking about using. They can help you learn what is known (or not known) about the method, which can help you make an informed decision. […] Whether you are thinking about treatment, getting treatment, or not being treated at all, you can still get supportive care to help with pain or other symptoms. […] For some people, when treatments have been tried and are no longer controlling the cancer, it could be time to weigh the benefits and risks of continuing to try new treatments. […] Remember that even if you choose not to treat the cancer, you can still get supportive care to help with pain or other symptoms.

• #114 Synovial Sarcoma Treatment & Management: Approach Considerations, Chemotherapy, Surgical Therapy

  https://emedicine.medscape.com/article/1257131-treatment

  There are no contraindications for surgical treatment of synovial sarcoma (also referred to as synovial cell sarcoma), which is potentially life-saving. There is a relative contraindication for treating these patients in primary centers. Early referral to tertiary centers for definitive treatment must be preferred. Ideally, treatment should be performed by a multidisciplinary team with personnel experienced in the management of soft-tissue sarcomas. […] Adjuvant chemotherapy and neoadjuvant chemotherapy have been proposed for patients with metastatic soft-tissue sarcomas. Although chemotherapy in the treatment of synovial sarcoma has been controversial, some studies have shown overall survival benefits in selected patients. […] Ladenstein et al reported improved survival rates with the use of adjuvant doxorubicin- and cyclophosphamide-based chemotherapy.

• #115 Treatments for soft tissue sarcoma | Canadian Cancer Society

  https://cancer.ca/en/cancer-information/cancer-types/soft-tissue-sarcoma/treatment

  If you have soft tissue sarcoma, your healthcare team will create a treatment plan just for you. It will be based on your health and specific information about the cancer. When deciding which treatments to offer for soft tissue sarcoma, your healthcare team will consider: […] The care and treatment of people with soft tissue sarcoma is often done by a healthcare team that is experienced in dealing with soft tissue sarcoma. Most cases of soft tissue sarcoma need to be managed by many specialists, including a radiologist, surgeon, medical oncologist and radiation oncologist. […] Surgery is usually the primary treatment for stage 1 soft tissue sarcoma. […] Surgery is usually the primary treatment for stage 2 and 3 soft tissue sarcomas. […] Stage 4 soft tissue sarcoma can be treated with a combination of therapies, including chemotherapy, radiation and surgery.

• #116 Sarcoma Treatment Centers – SFA

  https://curesarcoma.org/support-resources/treatment-centers/

  Because sarcomas are rare, it is important to find physicians and multidisciplinary treatment centers that have experience with this disease. […] The Sarcoma Foundation of America recognizes sarcoma treatment centers that meet the following criteria: […] A sarcoma medical group consisting of all specialties, including surgical, orthopedic and medical oncologists; radiologists; pathologists; and oncology nursing as well as rehabilitation services. […] At least one group member who belongs to a sarcoma-oriented medical organization, such as the Connective Tissue Oncology Society (CTOS). […] Publications concerning sarcoma in peer-reviewed journals. […] Sarcoma conferences (e.g. Tumor Board), where sarcoma group members meet at least once per month to discuss patient care issues. […] At least 50 sarcoma patients seen per year.

• #117 Sarcoma Treatment Centers – SFA

  https://curesarcoma.org/support-resources/treatment-centers/

  MRI imaging available; PET scans desired. […] Patient enrollment in clinical trials. […] Strong support personnel such as social workers, psychologists and psychiatrists. […] Sarcoma support group desired. […] Help us move closer to a world where people do not die from sarcoma. […] Don’t be the last to know! Join over 50,000 members of the sarcoma community who get the latest research updates, information about treatments and trials, education opportunities, and ways to get involved.

• #118 Bone Cancer and Soft Tissue Sarcoma | Froedtert & MCW

  https://www.froedtert.com/sarcoma

  Sarcoma Treatment Approaches Treatment for patients in the Sarcoma Program centers on the person and the disease. World-class specialists from multiple disciplines collaborate on individualized plans that are developed to destroy the cancer and to preserve or restore function. […] Treatment planning begins in a multidisciplinary tumor board that focuses solely on sarcoma patients. Physicians and other experts from every specialty involved in sarcoma care gather weekly to review and discuss cases and recommend treatment to destroy cancer and to preserve or restore limb function. […] Because our sarcoma team is constantly pursuing research to find new ways to detect and treat sarcoma or improve patients quality of life, they are knowledgeable about the latest and most effective treatments possible, including sarcoma clinical trials.

• #119 Treatment of Soft Tissue Sarcomas, by Stage | American Cancer Society

  https://www.cancer.org/cancer/types/soft-tissue-sarcoma/treating/by-stage.html

  The best chance to cure a soft tissue sarcoma is to remove it with surgery, so surgery is part of the treatment for all soft tissue sarcomas whenever possible. It’s important that your surgeon and other doctors are experienced in the treatment of sarcomas. These tumors are hard to treat and require both experience and expertise. Studies have shown that people with sarcomas tend to have better outcomes when they’re treated at specialized cancer centers that have experience in sarcoma treatment. […] Treatment is generally similar for most types of soft tissue sarcoma, especially for earlier stage sarcomas. But in recent years, as doctors have learned more about the differences between the types, newer targeted therapy and immunotherapy drugs have become important treatment options for some types of advanced soft tissue sarcomas.

• #120 Synovial Sarcoma Treatment & Management: Approach Considerations, Chemotherapy, Surgical Therapy

  https://emedicine.medscape.com/article/1257131-treatment

  There are no contraindications for surgical treatment of synovial sarcoma (also referred to as synovial cell sarcoma), which is potentially life-saving. There is a relative contraindication for treating these patients in primary centers. Early referral to tertiary centers for definitive treatment must be preferred. Ideally, treatment should be performed by a multidisciplinary team with personnel experienced in the management of soft-tissue sarcomas. […] Adjuvant chemotherapy and neoadjuvant chemotherapy have been proposed for patients with metastatic soft-tissue sarcomas. Although chemotherapy in the treatment of synovial sarcoma has been controversial, some studies have shown overall survival benefits in selected patients. […] Ladenstein et al reported improved survival rates with the use of adjuvant doxorubicin- and cyclophosphamide-based chemotherapy.

• #121 Treating Soft Tissue Sarcomas | Soft Tissue Sarcoma Treatments | American Cancer Society

  https://www.cancer.org/cancer/types/soft-tissue-sarcoma/treating.html

  Clinical trials are carefully controlled research studies that are done to get a closer look at promising new treatments or procedures. Clinical trials are one way to get state-of-the-art cancer treatment. […] You may hear about alternative or complementary methods to relieve symptoms or treat your cancer that your doctors havent mentioned. […] Be sure to talk to your cancer care team about any method you are thinking about using. They can help you learn what is known (or not known) about the method, which can help you make an informed decision. […] Whether you are thinking about treatment, getting treatment, or not being treated at all, you can still get supportive care to help with pain or other symptoms. […] For some people, when treatments have been tried and are no longer controlling the cancer, it could be time to weigh the benefits and risks of continuing to try new treatments. […] Remember that even if you choose not to treat the cancer, you can still get supportive care to help with pain or other symptoms.

• #122 Medications for Soft Tissue Sarcoma | NYU Langone Health

  https://nyulangone.org/conditions/soft-tissue-sarcoma/treatments/medications-for-soft-tissue-sarcoma

  Chemotherapy and targeted medication side effects may include nausea, vomiting, diarrhea, and lowered levels of red and white blood cells. Low red blood cell levels cause anemia, a condition that can lead to fatigue and shortness of breath. Low white blood cell levels can increase the risk of infection. […] All of these side effects can be managed with medications or other therapies prescribed by your doctor. Specialists at NYU Langones Perlmutter Cancer Center support you through chemotherapy with a variety of services, from support groups to holistic wellness programs. Your doctor can evaluate your symptoms and connect you with the support services that best suit your needs.

• #123 Get treatment for sarcoma | OHSU Knight Cancer Institute

  https://www.ohsu.edu/knight-cancer-institute/sarcoma-diagnosis-and-treatment

  Surgery […] Radiation therapy […] Chemotherapy […] Targeted therapy […] Immune therapy. […] Surgery is the most common treatment for sarcoma. […] Our surgeons use exceptional precision and advanced technology. […] We use minimally invasive techniques. […] We have one of the most comprehensive robotics programs on the West Coast. […] Some patients may need to have part of a bone surgically removed. […] In radiation therapy, doctors aim beams of energy, such as X-rays, at cancer cells to kill them. […] We may treat some types of sarcoma with chemotherapy. […] Chemotherapy fights cancer with drugs that kill cancer cells. […] Targeted therapy is a powerful type of treatment that homes in on a molecular target located on cancer cells. […] Our doctors led a clinical trial showing regorafenib, a targeted therapy drug, can help patients with advanced bone sarcoma. […] Immunotherapy harnesses the power of your own immune system to knock out cancer cells. […] Support and follow-up care is a critical part of your treatment. […] We offer a wide range of support services: […] Learn more about our supportive care at the Knight Cancer Institute.

• #124 Treatment for soft tissue sarcoma – NHS

  https://www.nhs.uk/conditions/soft-tissue-sarcoma/treatment/

  if you have certain types of sarcoma that respond well to chemotherapy […] to slow the growth of the cancer and relieve your symptoms if it has spread. […] Targeted medicines kill cancer cells. […] They are sometimes used to slow the growth of certain types of soft tissue sarcomas and help you live longer. […] If youve been diagnosed with advanced soft tissue sarcoma, it might be hard to treat and not possible to cure. […] The aim of your treatment will be to slow down the growth and spread of the cancer and its symptoms, and help you live longer. […] They will work with you to help manage your symptoms and make you feel more comfortable.

• #125 Treatment types | Sarcoma UK

  https://sarcoma.org.uk/about-sarcoma/treating-sarcoma/treatment-types/

  The type of treatment you receive will depend on the stage and grade of your cancer and the type of sarcoma you have. […] In a lot of cases, surgery is the first treatment method used for sarcoma sometimes with additional radiotherapy or chemotherapy. […] This treatment uses high-energy radiation beams to destroy cancer cells. […] It can be offered either before or after surgery to reduce the risk of your cancer recurring. […] This treatment uses anti-cancer drugs to destroy cancer cells. […] Its main use is in treating bone sarcomas, usually before or after surgery, or if surgery is not possible / the tumour cannot be completely removed. […] You may be offered an opportunity to take part in a study to investigate new diagnosis methods, drugs or treatments. […] Palliative care aims to improve the quality of life of anyone facing problems associated with advanced, progressive or life-limiting illnesses.

• #126 Get treatment for sarcoma | OHSU Knight Cancer Institute

  https://www.ohsu.edu/knight-cancer-institute/sarcoma-diagnosis-and-treatment

  Dr. Kenneth Gundle, an orthopaedic surgeon at OHSU, focuses on treating patients with bone tumors and sarcomas. […] The OHSU Knight Cancer Center has outstanding depth of experience in treating sarcoma: […] We’re a Sarcoma Center of Excellence. […] Our sarcoma clinic treats hundreds of patients every year. […] Our sarcoma experts work together to give you the benefit of the entire team’s knowledge. […] We lead clinical trials for access to promising new sarcoma treatments. […] We use advanced 3D technology to replace bone if needed. […] We offer a full range of support services for you and your family, including physical therapy and rehabilitation. […] Your treatment depends on the type of sarcoma you have, where it is and whether it has spread. We offer the latest therapies, including:

• #127 Synovial Sarcoma Treatment & Management: Approach Considerations, Chemotherapy, Surgical Therapy

  https://emedicine.medscape.com/article/1257131-treatment

  Preoperative radiation therapy (RT) is associated with an increased rate of wound problems. This neoadjuvant RT is sometimes proposed before surgery to reduce the size of the tumor. […] RT is usually required in addition to surgery, particularly if the margins are close to vital neurovascular structures. The most common form of RT in this setting is external-beam RT (EBRT) that is directed at the tumor site and that includes a margin of surrounding normal tissue. […] The local radiation dose is usually 40-60 Gy. […] The surgical complications are related to the site involved but include the general complications of wound infection, wound breakdown, neurologic or vascular injury, and hematoma or seroma formation. […] Specific complications associated with this tumor are local recurrence and distant metastases. The risk of local recurrence is directly proportional to the adequacy of surgical clearance. Therefore, a wide excision is mandatory to reduce this risk. […] Follow-up involves clinical examination, MRI of the surgical site, and CT of the chest. After surgical treatment, the authors recommend MRI, CT, and a patient review every 3-6 months for the first 2 years and then every 6 months for the next 3 years.

• #128 Sarcoma Treatment Centers – SFA

  https://curesarcoma.org/support-resources/treatment-centers/

  Because sarcomas are rare, it is important to find physicians and multidisciplinary treatment centers that have experience with this disease. […] The Sarcoma Foundation of America recognizes sarcoma treatment centers that meet the following criteria: […] A sarcoma medical group consisting of all specialties, including surgical, orthopedic and medical oncologists; radiologists; pathologists; and oncology nursing as well as rehabilitation services. […] At least one group member who belongs to a sarcoma-oriented medical organization, such as the Connective Tissue Oncology Society (CTOS). […] Publications concerning sarcoma in peer-reviewed journals. […] Sarcoma conferences (e.g. Tumor Board), where sarcoma group members meet at least once per month to discuss patient care issues. […] At least 50 sarcoma patients seen per year.

• #129 Soft Tissue Sarcoma Treatment Program | Massachusetts General Hospital

  https://www.massgeneral.org/cancer-center/treatments-and-services/sarcoma/soft-tissue-sarcoma

  Our multidisciplinary team of specialists provides comprehensive treatment for patients with soft tissue sarcoma – cancers arising in tissue such as muscle, tendon, cartilage, fat, blood vessels and nerves. […] Our multidisciplinary team of cancer specialists provides comprehensive, individually tailored treatment for children and adults with soft tissue sarcoma cancers arising in tissue such as muscle, tendon, cartilage, fat, blood vessels, and nerves. […] Because sarcoma is so rare, it is important to seek treatment from experts with extensive experience in diagnosing and managing these rare cancers. […] Our program is one of the oldest, largest, and most experienced sarcoma treatment programs in the world. […] At the Center for Sarcoma and Connective Tissue Oncology, we offer cutting edge care and innovative surgical, medical oncology, and radiation oncology treatments designed to eradicate the tumor, prevent local recurrence, improve survival and optimize limb function.

• #130 Sarcoma Treatment Centers – SFA

  https://curesarcoma.org/support-resources/treatment-centers/

  Because sarcomas are rare, it is important to find physicians and multidisciplinary treatment centers that have experience with this disease. […] The Sarcoma Foundation of America recognizes sarcoma treatment centers that meet the following criteria: […] A sarcoma medical group consisting of all specialties, including surgical, orthopedic and medical oncologists; radiologists; pathologists; and oncology nursing as well as rehabilitation services. […] At least one group member who belongs to a sarcoma-oriented medical organization, such as the Connective Tissue Oncology Society (CTOS). […] Publications concerning sarcoma in peer-reviewed journals. […] Sarcoma conferences (e.g. Tumor Board), where sarcoma group members meet at least once per month to discuss patient care issues. […] At least 50 sarcoma patients seen per year.

• #131 Sarcoma Treatment Centers – SFA

  https://curesarcoma.org/support-resources/treatment-centers/

  MRI imaging available; PET scans desired. […] Patient enrollment in clinical trials. […] Strong support personnel such as social workers, psychologists and psychiatrists. […] Sarcoma support group desired. […] Help us move closer to a world where people do not die from sarcoma. […] Don’t be the last to know! Join over 50,000 members of the sarcoma community who get the latest research updates, information about treatments and trials, education opportunities, and ways to get involved.

• #132 Treatment of Soft Tissue Sarcomas, by Stage | American Cancer Society

  https://www.cancer.org/cancer/types/soft-tissue-sarcoma/treating/by-stage.html

  The best chance to cure a soft tissue sarcoma is to remove it with surgery, so surgery is part of the treatment for all soft tissue sarcomas whenever possible. It’s important that your surgeon and other doctors are experienced in the treatment of sarcomas. These tumors are hard to treat and require both experience and expertise. Studies have shown that people with sarcomas tend to have better outcomes when they’re treated at specialized cancer centers that have experience in sarcoma treatment. […] Treatment is generally similar for most types of soft tissue sarcoma, especially for earlier stage sarcomas. But in recent years, as doctors have learned more about the differences between the types, newer targeted therapy and immunotherapy drugs have become important treatment options for some types of advanced soft tissue sarcomas.

• #133 Soft Tissue Sarcoma Treatment Program | Massachusetts General Hospital

  https://www.massgeneral.org/cancer-center/treatments-and-services/sarcoma/soft-tissue-sarcoma

  Our multidisciplinary team of specialists provides comprehensive treatment for patients with soft tissue sarcoma – cancers arising in tissue such as muscle, tendon, cartilage, fat, blood vessels and nerves. […] Our multidisciplinary team of cancer specialists provides comprehensive, individually tailored treatment for children and adults with soft tissue sarcoma cancers arising in tissue such as muscle, tendon, cartilage, fat, blood vessels, and nerves. […] Because sarcoma is so rare, it is important to seek treatment from experts with extensive experience in diagnosing and managing these rare cancers. […] Our program is one of the oldest, largest, and most experienced sarcoma treatment programs in the world. […] At the Center for Sarcoma and Connective Tissue Oncology, we offer cutting edge care and innovative surgical, medical oncology, and radiation oncology treatments designed to eradicate the tumor, prevent local recurrence, improve survival and optimize limb function.

• #134 Soft Tissue Sarcoma Treatment Experts | UVA Health

  https://uvahealth.com/services/cancer/soft-tissue-sarcoma

  Sarcoma can be treated. But it’s important to have your care at a center with sarcoma treatment expertise. […] At UVA Health, you’ll find experts who’ve devoted their careers to helping patients like you fight soft tissue sarcoma. These experts will lead your care. They work as a team to enhance your treatment. […] We’ll design a personalized treatment plan based on your type of cancer and you. You’ll have surgeons, radiation therapists, and chemotherapy specialists on your side. […] You may need all or some of the different types of treatment. These include: […] Surgery to remove the cancerous tumor, nearby tissue, and possibly nearby lymph nodes. […] Radiation therapy or radiotherapy to kill cancer cells and shrink tumors. Radiation after surgery significantly reduces the chances of the cancer coming back. At UVA Health, we use the most advanced radiation therapy tools.

Zobacz więcej